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ABSTRACT 
The accomplishment of pilot implementation of the HIVQUAL-T model, an innovative HIV 
care quality management tool, has led to an authoritative decision to scale up the use of the model 
nationwide in Thailand. However, the level of implementing this model varies across target hospitals. 
Some hospitals have fully adopted the model by conducting quality improvement (QI) activities 
following performance measurement (PM) results while others have partially adopted only PM or 
have not used this model at all. The differential level of implementation could be a contributing 
factor accounting for discrepancies in the quality of care across different HIV ambulatory care 
facilities.  
A cross-sectional study was conducted by using two main datasets, including Thailand‘s 
national HIV care performance results and an online survey of all public hospitals nationwide. A 
total of 382 hospitals responded to the survey, accounting for a response rate of 50%. A 
confirmatory factor analysis (CFA) method was performed to examine the validity of latent 
constructs developed from the diffusion of innovation theory. Structural equation modeling 
(SEM) approach was employed to investigate the relationship between the determinants of 
organizational decision-making and their contribution to organizational outcomes, under the 
context-design-performance framework. Furthermore, using a panel model of hospitals that 
reported performance results across a 3-year period, the improvement in HIV ambulatory 
services performance among the adopters was examined.  
The results indicated that two innovation attributes – relative advantage and simplicity 
perceived by HIV care practitioners in hospitals – were found to be positively associated with the 
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level of the HIVQUAL-T model implementation. Two structural characteristics – 
interconnectedness and organizational slack – appeared to be positively associated with the level 
of model implementation, while rate of adoption in the region also had significant positive 
contribution. Ultimately, the extensiveness of the HIVQUAL-T model implementation 
demonstrated a proportionate impact on the variation in hospitals‘ HIV ambulatory services 
performance. It was noted that the implementers considerably improved their performance within 
two years of implementing the model. 
The study findings imply that adoption is more likely when individual practitioners assess 
the innovation and find it to be easy to comprehend and operate and also worthwhile to 
implement. Furthermore, hospitals‘ decision making is likely influenced by their relations to 
external environment. The findings suggest more emphasis on individual and hospital-level 
capacity building for meaningful use of this quality management initiative, accompanied by an 
adjustment of performance measurement software with valid, reliable, and interpretable 
indicators. 
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CHAPTER ONE: INTRODUCTION 
 This study investigated organization structural characteristics and individuals‘ perceptions 
that could determine the adoption of a quality management model, and the extent to which 
differential adoption of the model could improve HIV ambulatory service performance. The study 
was conducted in Thailand with a nationwide survey of all hospitals with an HIV care unit that were 
introduced with the model in the year 2007. This chapter addresses the study background and 
significance of the problem, along with research questions, theoretical context, scope of the study, 
and definition of the terms used in the study. 
Current HIV/AIDS Setting: A Focus on HIV Care Quality 
The response to the human immunodeficiency virus (HIV) pandemic is critical to progress 
across the global development agenda. Over the past three decades, many countries have stepped up 
efforts with multisectoral, multinational alliances to fight the epidemic. After the AIDS epidemic 
passed its peak in 1999, the number of new infections decreased by 19% globally (UNAIDS, 2010). 
Despite the significant decline, HIV/AIDS, as a chronic disease with a multifaceted nature, 
requires access to comprehensive care from health care professionals. Currently, HIV-infected 
patients‘ life expectancies have increased through the delivery of clinical care and treatment services, 
particularly antiretroviral therapy, prophylaxis and treatment of opportunistic infections, general 
medical health screenings, promotion of healthy activities, and retention in medical care (Horberg et 
al., 2010). There are more than 5 million people around the world receiving HIV treatment as of 
2009 (UNAIDS, 2010). Yet the need for intensified action to move towards the access to HIV service 
  
2 
delivery to HIV prevention, treatment, care, and support persists, and in particular, the monitoring 
and evaluation of HIV care is essential in order to improve clinical service delivery and ultimately 
the quality of life of people living with HIV/AIDS (PLHA) (Avert, 2010).  
HIV Care and Treatment, and Monitoring System in Thailand 
Thailand, among developing countries encountering HIV/AIDS problems, has instituted a 
series of successful campaigns that helped to reduce the HIV prevalence nationally (Tantives & Walt, 
2006). The rate of infection in Thailand continues to decrease over time. The number of people 
newly infected with HIV is estimated to have fallen from approximately 140,000 in 1991 to 10,097 
in 2011 (Avert, 2010; National AIDS Prevention and Alleviation Committee, 2010), with a 
significant decline of AIDS-related deaths from 8,589 in 2001 to 1,276 cases in 2009 
(Epidemiological Information Section, 2010). 
As indicated by the Asian Epidemiological Model (AEM) projection, the estimated number 
of PLHA who met the indications for highly active antiretroviral therapy (HAART) criteria in 2008 
and 2009 was 266,369 and 275,621, respectively. Thailand‘s nationwide scaling up to increase ART 
coverage was deemed to be successful; however, 25% of the eligible PLHA are still without access. 
Among those treated, 85% are known to still be under treatment 12 months after initiation of ART, 
according to the indicator data reported to the United Nations General Assembly Special Session 
(UNGASS) in 2010 (National AIDS Prevention and Alleviation Committee, 2010). Yet, there has not 
been much evidence of other HIV care indicators, such as opportunistic infection prophylactic 
treatment or baseline screening services, reported officially.  
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In 2007, the National Health Security Office (NHSO) introduced the National AIDS Program 
(NAP) Database system to monitor PLHA care and treatment throughuot the country. The core 
modules of the NAP system consist of registration, following, authorization for second line ARV, 
laboratory request, and reports. This paperless system also includes four additional modules: 
voluntary counseling and testing (VCT), prevention of mother-to-child transmission (PMTCT), 
postexposure prophylaxis, and reporting systems (National AIDS Prevention and Alleviation 
Committee, 2010). In the meantime, the Ministry of Public Health, Bureau of AIDs, TB, and STIs 
(BATS) has nationally introduced the ‗HIVQUAL-T‘ model for evaluating HIV ambulatory service 
performance in which hospitals all over the country have to report their performance evaluation 
results annually (BATS, 2011). The HIVQUAL-T model is now adjusted to be compatible with the 
NAP data (National AIDS Prevention and Alleviation Committee, 2010). 
The ‘HIVQUAL’ Model: A Quality Management Initiative for HIV Care 
Performance measurement is an essential element in any quality improvement strategy. It 
provides health care practitioners with the diagnostic information they need to make informed 
improvement decisions. Thus, measuring clinical performance could be regarded as an important 
step in providing better care for patients (NYS Department of Health AIDS Institute, 2006). 
There have been attempts to develop HIV care quality measures to monitor and evaluate HIV 
clinical performance at the system level, clinic level, and individual level (AMA & NCQA, 
2008; Backus et al., 2010; Horberg et al., 2010).  
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HIVQUAL-U.S. 
The New York State Department of Health AIDS Institute (NYSAI) initiated an HIV Quality 
of Care program in New York State in 1992, which later was expanded to HIV ambulatory clinics 
throughout the U.S. under the title ―the National HIVQUAL Project.‖ Sponsored by the U.S. 
Department of Health and Human Services, Health Resources and Services Administration 
(HRSA)‘s HIV/AIDS Bureau, the HIVQUAL software is offered to participants at no cost and is 
designed to facilitate monitoring of HIV clinical care based on clinical practice guidelines developed 
by the NYSAI (U.S. Department of Health and Human Services, Health Resources and Services 
Administration (HRSA), 2011). The program is accountable for the systematic monitoring of medical 
care quality and support services for HIV-infected people (Horberg et al., 2010; Warner, Drainoni, 
Parker, Agins, & Eldred, 2004). Most recently, the HIV/AIDS Expert Panel Work Group has 
coordinated multiple HIV quality measures developed by many organizations, including HIVQUAL 
indicators. The HIV quality measures created are formally approved and are now being ―beta tested‖ 
by a few organizations. It is expected that many of these measures could serve as quality 
improvement elements to resolve gaps in care and to ensure continued success of quality HIV care 
(Horberg et al., 2010). The HIVQUAL program has now been adopted and implemented in 12 
developing countries around the world. Each country applies similar core clinical indicators with 
additional indicators that are culturally adjusted to serve their HIV care setting 
(http://healthqual.org/). 
HIVQUAL-Thailand 
 As the first to implement the HIVQUAL model outside the U.S., Thailand‘s Ministry of 
Public Health along with the U.S. Centers for Disease Control and Prevention Collaboration (TUC) 
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have developed the HIVQUAL-T Model, a Thai version of the HIV quality management initiative 
originally created by the NYSAI. As a monitoring and evaluation tool for HIV care, the model 
comprises three core components, including 1) performance measurement (PM) with HIVQUAL-T 
software and indicators based on national guidelines for HIV/AIDS care and treatment; 2) quality 
improvement (QI) activities following performance data derived from the measurement; and 3) 
infrastructure development for building hospital-level capacity to interpret performance data, 
prioritize quality needs, and implement QI processes. The performance assessment and quality 
improvement activities are guided and facilitated through interactive group learning with experienced 
implementers (Ningsanond, et al., 2008; Utaipiboon, 2011). The current core indicators for 
measuring HIV ambulatory service performance include HIV status monitoring with CD4 cell and 
viral load tests; primary opportunistic infection (OI) prophylaxis; antiretroviral therapy medication; 
disease screening (e.g., tuberculosis, cervical cancer, CMV retinitis, sexually transmitted infections, 
hepatitis B/C); and health promotion (e.g., health education, mental health assessment, HIV 
disclosure to partner) (BATS, 2011). 
Adoption and Diffusion of the HIVQUAL-T Software 
 In 2002, the HIVQUAL-T Model was adopted in pilot sites that reported the most number of 
people living with HIV/AIDS, which resulted in a better quality of HIV ambulatory services. The 
evaluation of the HIVQUAL-T model in pilot sites showed a gradually increasing percentage in most 
core performance indicators as the result of QI projects for eligible patients receiving care and 
treatment from 2003 to 2006 (BATS, 2011). There have been efforts to promote the model to all 
public hospitals nationwide and to integrate the practice into a national hospital accreditation system 
in order to facilitate national expansion (Supawitkul, 2006). Numbers of the HIVQUAL-T adopters 
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increased from 12 pilot hospitals in 2002 to 228 hospitals in 2006. The Bureau of AIDS, TB, and 
STIs (BATS) is now encouraging all public and private hospitals to report their HIV clinical service 
performance using the HIVQUAL-T software and is aiming for the expansion of the HIVQUAL-T 
system to cover 900 hospitals by 2011 (BATS). 
Although the accomplishment of its pilot implementation is obvious, the Ministry‘s attempt 
to nationally scale-up the use of HIVQUAL-T model by providing HIVQUAL-T training in 2007 
throughout the country convinced only 52% of the participating hospitals to submit their performance 
reports as of 2008 (Ningsanond et al., 2008). The number of hospitals that submitted the reports 
slightly decreased in 2009, which could imply that some hospitals may disengage from using the 
software after adoption. Furthermore, among the adopters, some hospitals reported only the use of 
HIVQUAL-T performance measurement software but did not report the extensive implementation of 
quality improvement projects using the measurement results, which is the second element of the 
model. Such differential adoption and implementation of the HIVQUAL-T model at the national 
level may entail the significance of factors additional to institutional influences related to the 
hospitals‘ decision making to put the model into operation. Although, according to the information 
from BATS, overall HIV ambulatory services quality has improved over time after the nationwide 
expansion during 2007–2009, little is known about the variation in quality across different facilities 
that vary in their structures and level of HIVQUAL-T model implementation.  
Consequently, understanding HIV care practitioners‘ perceptions of the attributes of the 
HIVQUAL-T model and the hospitals‘ organizational structural characteristics is essential for 
profiling HIV clinics‘ quality management practice. The investigation of HIV care practitioners‘ 
perceptions could lead to the adjustments of the HIVQUAL-T model attributes and the early 
  
7 
adaptation of health care providers towards new interventions. Identifying organization structural 
characteristics could also help to determine organizational decision-making and organizational 
innovativeness, which may contribute to better organizational performance. Additionally, examining 
the extent to which the use of the HIVQUAL-T model could lead to hospitals‘ better delivery of 
appropriate HIV clinical care and treatment services on a wider scale would help to demonstrate the 
effectiveness of this initiative.  
Research Questions 
 This study examined the relationships among contextual factors, structural factors, 
organizational decision making, and organizational performance in two aspects: 1) perceived 
innovation attributes and organizational structural characteristics as predictors for hospitals‘ 
innovation adoption, and 2) the extent of HIVQUAL-T model adoption contributing to HIV 
ambulatory services quality. In examining these relationships, the primary research questions of 
this study are as follows: 
 Q1: To what extent do innovation attributes, as perceived by HIV care practitioners, 
contribute to the variation in HIVQUAL-T model adoption among hospitals? 
 Q2: To what extent do organizational structural characteristics contribute to the variation 
in HIVQUAL-T model adoption among hospitals? 
 Q3: Do different levels of HIVQUAL-T model adoption contribute to the variation in 
HIV ambulatory care and treatment services performance among hospitals?  
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Theoretical Context 
 HIVQUAL-T model was first introduced to 12 hospitals in Thailand in 2002 as a new 
approach for HIV ambulatory service quality management and is now expanding to all hospitals 
nationwide. It is expected that 914 hospitals, both public and private, would be implementing the 
HIVQUAL-T model by 2011 (BATS, 2011). The present study applies Everett M. Rogers‘ Diffusion 
of Innovation theory to explore the influence of innovation attributes and organization structural 
characteristics on hospitals‘ decision making. Rogers (2003) defined ‗innovation‘ as ―the idea, 
practice, or object that is perceived as new by an individual or other unit of adoption…whether or not 
an idea is objectively new as measured by the lapse of time since its first use of discovery‖ (p. 12). 
Newness in an innovation need not just involve new knowledge but may be expressed in terms of 
knowledge, persuasion, or a decision to adopt.  
 The characteristics of innovations, as perceived by individuals in a system, can help explain 
their different rate of adoption. The perceived attributes of innovation include relative advantage, 
compatibility, complexity, trialability, and observability (Rogers, 2003). However, research on the 
influence of innovation attributes on organizational adoption is rare (Rye & Kimberly, 2007). 
Perceived compatibility, perceived ease of use, relative advantage, and observability are found to be 
associated with the adoption or intention to adopt a new technology (Damanpour & Schneider, 2008; 
Knudsen, Roman, & Johnson, 2003; Scott, Plotnikoff, Karunamuni, Bize, & Rodgers, 2008; Tung, 
Chang, & Chou, 2008). The study of HIVQUAL-T model attributes would help identify both 
desirable and undesirable characteristics of the innovation that influence hospitals‘ adoption 
decisions and also provide a theoretical contribution to the development and validation of innovation 
attribute constructs. 
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 Despite some similarities of characteristics associated with earliness of adoption (or 
innovativeness), organizations‘ innovation decision processes are more complex than individuals‘ 
processes. Rogers (2003) illustrated organizational structure variables related to the innovativeness of 
organizations including centralization, complexity, formalization, interconnectedness, and 
organizational slack. Organizational structural characteristics‘ contribution to organizational adoption 
has been studied in most innovation research employing diffusion of innovation and innovation 
theoretical perspectives (Damanpour & Gopalakrishnan, 2008; Hikmet, Bhattacherjee, Menachemi, 
Kahan, & Brooks, 2008; Kimberly & Cook, 2008; Kimberly & Evanisko, 1981; Moch & Morse, 
1977). Many studies of health care providers‘ innovation adoption found that organizational 
attributes such as hospital size, ownership, and policy also contribute to the adoption of innovation 
(Kaluzny, Glasser, Gentry, & Sprague, 1970; Kaluzny, Veney, & Gentry, 1974). In the study context, 
Thai public hospitals‘ structural characteristics generally vary across their levels of operation and 
capacity. An investigation of organizational determinants could identify some structural barriers to 
HIVQUAL-T model adoption among hospitals. A study of innovation adoption in a country with a 
unique context like Thailand‘s may provide a creative way to incorporate organizational culture into 
the explanation of structural characteristic constructs in innovation research as well.  
 According to Kovach, Morgan, Nooman, and Brondino (2008), diffusion of innovation is an 
effective model for making changes in performances of healthcare organizations. However, there are 
very few studies that examine the influences of the benefits of innovation on organizational adoption 
of innovation (Rye & Kimberly, 2007). The ultimate goal of HIVQUAL-T implementation, similar 
to the original HIVQUAL program initiated in the U.S., is to improve quality of HIV care (Agins, et 
al., 2004; Drainoni, Warner, & Johnson, 2002). Since HIVQUAL-T was reported to increase HIV 
clinical service performance in pilot sites, an investigation of the performance of HIV ambulatory 
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care and treatment practice in relation to the HIVQUAL-T adoption would reflect the extent that 
HIVQUAL-T implementation outcome has been accomplished, particularly in the period during 
which the healthcare setting put more focus on quality management and medical facility 
performance. 
Moreover, there have been no studies, as reported to date, that systematically investigate a 
whole policy implementation process by considering contextual factors, organizational structure, 
individual perceptions, organizational practices, and organizational performance all together using a 
system approach jointly with innovation diffusion theory. Thus, this study sought to shed light on the 
application of innovation diffusion theory further than its conventional purposes by linking the 
theoretically informed constructs to adoption decision making, organizational innovativeness, and 
organizational performance in its hypothesized model.  
Scope of the Study 
 For the purpose of this study, the implementation of HIVQUAL-T model was defined as the 
hospital practices on performance measurement and quality improvement in HIV clinical service 
delivery. As the nationwide scaling-up program emphasized capacity building for HIV care 
practitioners, it was expected that the practitioners‘ perceptions on the HIVQUAL-T model would 
play an important role in adoption decision-making and implementation at the hospital level, in 
concurrence with organizational structural characteristics. However, some environmental factors 
such as market competition were not covered in this study. Since the focal populations are public 
hospitals classified as regional, general, and community hospitals serving local areas, they are not 
subjected to a competitive environment. On the other hand, a contextual determinant considered in 
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this study was the adoption rate at the regional level, which implied the facilitation of performance 
measurement and quality improvement implementation through peer-to-peer learning, as indicated 
previously as a component of the HIVQUAL-T philosophy. In addition, as this study aimed to 
examine the extent that the adoption in the nationwide scaling-up period would contribute to better 
HIV clinical service delivery, pilot hospitals that implemented this model during the years 2003–
2005 were excluded from the study population in order to rule out the impact of the length of 
exposure to the HIVQUAL-T model.  
 This study focused on the adoption and implementation of the model at 828 public hospitals 
in Thailand. The inclusion criteria for the selected hospitals included hospitals that 1) are public 
hospitals operating under the Ministry of Public Health; 2) never participated in HIVQUAL-T pilot 
implementation during the years 2003–2005; 3) never adopted and implemented the HIVQUAL-T 
model prior to the year 2006; 4) had submitted at least one HIV clinical care performance assessment 
report during the years 2006–2009 or never submitted any performance reports to BATS.  
 In dealing with theoretical latent constructs, this study used the confirmatory factor analysis 
(CFA) technique. Structural equation modeling (SEM) was employed to generate theoretically 
informed models to explain and examine complex relationships among multiple exogenous and 
endogenous variables. A cross-sectional analysis was conducted in order to compare the relative 
importance among the determinants of innovation adoption and variability of organizational 
performance regarding the differentials in adoption. A univariate analysis was performed with a 
panel model of hospitals‘ HIV clinical service performance across a 3-year period (2007–2009) in 
order to examine the improvement of their performance among the adopters.  
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 Since the HIVQUAL-T model is dynamic by nature, with its measures of service quality 
applicable to varying HIV care settings, such as pediatric care, prevention, education, and so on, this 
study examined only the ambulatory care aspect of the hospitals‘ performance. The measures 
comprised six core indicators for baseline HIV care in a hospital: CD4 and viral load testing, 
opportunistic infection (OI) prophylaxis, antiretroviral therapy (ART), tuberculosis (TB) screening, 
sexually-transmitted infections (STIs) screening, and cervical cancer screening for women (PAP 
smear).  
Definitions of Terms Used in the Study 
Innovation 
 In this study, innovation was conceptualized, as stated by Rye and Kimberly (2007), as a 
―discrete, already developed material artifact or practice‖ (p. 240) that is put into use for the first 
time, regardless of whether the practice is objectively new or has ever been introduced or 
implemented in other organizations (Rogers, 2003). The study considered the HIVQUAL-T model as 
the focal innovation that has two main administrative components: performance measurement and 
quality improvement. 
Adoption 
 This study defined adoption as the application of the technology: HIVQUAL-T software and 
implementation of quality improvement activities regarding performance assessment results in 
hospitals. HIVQUAL-T model adoption represented hospitals‘ decisions to bring the HIVQUAL-T 
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model into full use and their active participation to report their performance measurement results and 
quality improvement practices to the Ministry of Public Health.  
Extensiveness of Innovation Adoption 
 Extensiveness of innovation adoption was defined as the extent to which hospital practices 
cover the two main components of the HIVQUAL-T model; thus, this term implied the level of 
completeness of the implementation in each hospitals, which ranged from no adoption (neither PM 
nor QI) to partial adoption (only PM) to full adoption (both PM and QI).  Unlike other technologies, 
for which adoption is generally measured dichotomously at a single time point of the decision to use, 
the HIVQUAL-T model incorporates differing combinations of practice; therefore, the extensiveness 
of HIVQUAL-T adoption was divided into three stages: 1) no adoption, indicating no 
implementation of the model at all; 2) partial adoption, indicating the adoption of only performance 
measurement, the first component of the model; and 3) full adoption, indicating the adoption of 
performance measurement in first years of practices, followed by the implementation of quality 
improvement projects in later years.  
HIV Services Performance 
 HIV services performance was defined as the extent to which a hospital could provide 
eligible patients with appropriate ambulatory services, including HIV status monitoring, treatment, 
prophylactic medicine, and disease screening. The study applied the concepts of HIV care and 
treatment according to the national guideline by measuring six aspects of HIV ambulatory care for 
outpatients: including viral load and CD4 screening, antiretroviral therapy, opportunistic infection 
  
14 
prophylaxis, tuberculosis screening, sexually transmitted infections screenings, and cervical cancer 
screening for women.  
Perceived Innovation Attributes 
 Perceived innovation attributes was defined as the prospective adopters‘ perception of the 
characteristics of the innovation; thus, its measure was subjective and reflected secondary attributes. 
Five attributes were identified by Rogers (2003), including relative advantages, compatibility, 
complexity, trialability, and observability, were used in this study to explain HIV care practitioners‘ 
decision to adopt the HIVQUAL-T model.  
Organization Structural Characteristics 
 This study defined organizational characteristics as internal characteristics of an organization 
that could influence innovation adoption behaviors of the adopters (Rogers, 2003). Organization 
structural characteristics included organizational centralization, complexity, formalization, 
interconnectedness, and organizational slack that were considered as determinants of HIVQUAL-T 
model adoption among hospitals at the time the innovation was adopted and put into practice.  
Chapter Summary 
 The study‘s aims are to 1) explore the factors affecting the decision for HIVQUAL-T model 
adoption among hospitals in Thailand, and 2) investigate hospitals‘ HIV ambulatory services 
performance in relation to their extent of implementation of the model. The study of HIVQUAL-T 
model adoption could help policy decision makers and practitioners identify key components 
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contributing to the implementation of the model and the effectiveness of government intervention. 
Research findings could lead to the adjustments of HIVQUAL-T model attributes and the meaningful 
use of the model among healthcare providers. In addition, the study could provide a theoretical 
contribution in terms of the development and validation of construct measures as well as the 
application of diffusion of innovation theory in the culturally unique context of Thailand. 
 
 
CHAPTER TWO: LITERATURE REVIEW 
 Performance measurement, as a means of evaluating organizational effectiveness, 
encouraging improvement, and making decisions for resource allocation, has become a significant 
part of quality management in health care, particularly in the domain of chronic disease ambulatory 
care settings within which the health status of patients has to be continuously monitored and 
assessed. The philosophy of the HIVQUAL model developed by the New York State Department of 
Health AIDS Institute emphasizes the ongoing measurement of HIV ambulatory care performance 
for quality improvement in clinical facilities. The model has been launched internationally since 
2003 in Thailand, and it has now been expanded to cover 12 countries worldwide. With the focus in 
Thailand, this study views the use of the HIVQUAL-T model as an innovation adoption process that 
began with the Ministry of Public Health‘s intervention in few pilot sites to implementation at the 
national scale. Thus, the theoretical framework employed in this study was based on a ―Diffusion of 
Innovation‖ perspective. This chapter presents an overview of diffusion of innovation theory; a 
review of the literature related to innovation adoption at the organizational level; a conceptual 
framework that portrays the relationship among contextual factors, organizational design, and 
organizational performance; and the study‘s theoretically informed hypotheses.  
Diffusion of Innovation Theory: Overview 
 Diffusion of innovation is a perspective developed by Everett M. Rogers in 1962 to describe 
a general diffusion model among various innovation research traditions (2003). Rogers‘ theory is 
considered the only theory that covers both individual and organizational innovation domains 
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(Jerayaj, Rottman, & Lacity, 2006). Diffusion of innovation theory seeks to explain the spread of 
new technologies or practices. For a study of organization, innovation, according to this perspective, 
refers to the process by which an organization puts a technology or practice into use for the first time, 
regardless of whether other organizations have previously used the technology or practice (Rogers, 
2003; Weiner, Helfrich, & Hernandez, 2006). A step for which the innovation represents application 
of a change is called ―adoption.‖ The process of incorporating new things within an organization can 
represent a strategic effort for that organization. Thus, innovation is a multiphase process, not a 
single event occurring at a single point of time (Pierce & Delbecq, 1977). The process of innovation 
diffusion is influenced by four main factors including the innovation itself, communication channels 
that enable the spread of the use of the innovation after it is adopted, time over which the 
communication is taken place, and a social system in which individuals or organizations are 
embedded (Rogers, 2003).  
Definition of Innovation 
 As a concept related to organizational change that deals with any modification in 
organizational composition, structure, or behavior (Weiner et al., 2006), the theory of innovation has 
been frequently used as an approach for viewing individual and organizational change among various 
disciplines while the definitions of innovation are not much different among them (Damanpour & 
Scheider, 2008; Weiner et al., 2006). There are five types of innovations as defined by Joseph 
Schumpter (1930), the first economist who drew attention to the importance of innovation: 1) the 
introduction of the new product or qualitative change in an existing product; 2) process innovation 
new to an industry; 3) the opening of the new market; 4) development of new sources of supply for 
raw materials or other inputs; and 5) changes in industrial organization (Rogers, 1998). 
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Anthropologist H. G. Barnett viewed innovation as a basis for cultural change and defined 
innovation as ―any thought, behavior, or thing that is new because it is qualitatively different from 
existing forms‖ (Robertson, 1967). For applying organizational perspective to innovation, 
Damanpour and Gopalakrishnan (1998) stated that innovation is an idea or behavior new to an 
organization. ―Innovation can be a product or a service, an organization process or an administrative 
program, a technology, or a policy, or a system related to organizational members‖ (p. 3).  
 Robertson (1967) illustrated the framework for classifying innovations with regard to their 
effects on established patterns. Innovation can be classified as continuous innovations, dynamically 
continuous innovations, or discontinuous innovations. Continuous innovations involve alteration of a 
product rather than the establishment of a new one while dynamically continuous innovations involve 
the creation of a new product or the alteration of the existing product but still not a change to the 
established patterns. The most disrupting influence comes from discontinuous innovations, which 
involve the establishment of a new product and also the establishment of new behavior patterns. 
Weiner et al. (2006) stated that innovation adoption and implementation processes may differ 
significantly for different types of innovations. Innovation researchers, particularly in the health care 
field, sometimes distinguish technological innovations from administrative innovations (Kimberly & 
Evanisko, 1981; Naranjo-Gil, 2009). However, Rogers (2003) stated that the words ―innovation‖ and 
―technology‖ are often used as synonyms. In his sense, technology comprises both material or 
physical objects and information, such as political philosophy or religious ideas. According to him, 
technology is a means of reducing uncertainty. Once decision makers seek information about a 
technology and find the cause–effect relationships on which the technology is based, a decision 
concerning adoption or rejection can be made.  
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Innovation Adoption  
 A step that innovation represents application of a change is called ―adoption.‖ Rogers defined 
adoption as ―the decision to make full use of the innovation as the best course of action available‖ (p. 
21). The decision to adopt an innovation is a consequence of the innovation-decision process through 
which an individual or other decision-making unit passes from first knowledge of an innovation to 
putting the innovation into use and finally to confirming the full use of the innovation (Rogers, 
2003). Adoption of innovation at the organizational level basically means that the innovation is new 
to the adopting units, who intend  to obtain expected benefits from changes that the innovation may 
bring to the organization (Damanpour & Schneider, 2008).  
As mentioned previously, innovations could be either physical forms or ideas. The adoption 
of some innovations, therefore, can be seen more clearly than the adoption of others. The 
concreteness of the innovation makes the operationalization of innovation vary, since organizations 
adopt innovation in a variety of ways, such as investing resources to purchase an innovation or hiring 
external consultants with specialized skills (Rye & Kimberly, 2007). For example, total quality 
management (TQM) represents both an innovative philosophy and a set of practices for improving 
the quality of health care services. Organizations adopt TQM by executing activities or interventions 
following TQM principles (such as conducting customer satisfaction surveys, providing employee 
training, or benchmarking). The measure of the adoption of such innovation would thus reflect 
discrete organizational decisions by managers‘ self-reports of activities or disseminated documents 
regarding the interventions (Projogo & Sohal, 2003; Rye & Kimberly, 2007; Young, Charns, & 
Shortell, 2001). Similarly, the HIVQUAL-T model involves the philosophy of quality management; 
thus, it encompasses both performance measurement using an assessment computer software and 
quality improvement as an intervention practice in HIV clinical service delivery system. Hence, in 
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this study the adoption of the HIVQUAL-T model is considered as a full use of these two main 
components.  
Diffusion of Innovation  
 Rogers (2003) defined diffusion as the ―process in which an innovation is communicated 
through certain channels over time among the members of social system. The diffusion of innovation 
is a kind of universal process of social change‖ (p.5). The diffusion of innovation has four main 
elements: innovation, communication channels, time, and a social system. When one individual 
delivers messages about innovation to others, communication channels are utilized as the means for 
the message delivery. Most intercommunication takes place when individuals share the same 
backgrounds or beliefs. The innovation-diffusion process, innovativeness, and an innovation‘s rate of 
adoption involve the time dimension. Additionally, the social system is a significant element as the 
context that allows the diffusion to take place. Social system is a set of interrelated units that are 
engaged in joint problem solving to accomplish a common goal, which establishes the behavior 
pattern for its members (Rogers, 2003). Hence, the diffusion aspect comprises both communication 
and sociological perspectives.  
 On account of its multidisciplinary nature, diffusion approach cuts across various scientific 
fields and makes significant contributions to various research disciplines. According to Rogers 
(2003), 58 % of diffusion research was accounted for by the study of innovativeness of members of a 
social system, which saw characteristics of member, and systems as determinants. Until recently, 
many studies still followed a similar framework (Aubert & Hamel, 2001; Carter & Belanger, 2005; 
Damanpour & Schneider, 2008; Ducharme, Knudsen, Roman, & Johnson, 2007; Escarce, Bloom, 
Hillman, Shea, & Schwartz, 1995; Hung, Hung, Tsai, & Jiang, 2010; Meyer, Johnson, & Ethington, 
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1997; Scott et al., 2008; Young et al., 2001). Other types of diffusion research include earliness of 
knowing innovations, rate of adoption on different innovations in a social system, opinion leadership, 
diffusion networks, rate of adoption in different social systems, communication channel usage, and 
consequences of innovation. Among organizational studies, the consequences of innovation mostly 
emphasized organizational performance, considering that organizations adopt innovation in order to 
improve their quality of services, efficiency, and effectiveness (Hikmet et al., 2008; Johnson, la 
France, Meyer, Speyer, & Cox, 1998; Kovach et al., 2008; Naranjo-Gil, 2009; Projogo & Sohal, 
2003). These intellectual paradigms enable scholars to follow the research direction. However, 
Rogers stated that the diffusion paradigm ―also impose[s] and standardize[s] … [a] set of 
assumptions and conceptual biases [that] are difficult to recognize and overcome,‖ which is a 
significant challenge for the next generation of diffusion scholars (Rogers, 2003, p. 101).  
Innovation and Social System  
 The perception of innovation characteristics as contributing to the attentiveness of using a 
technology allows individuals to exchange evaluation information about an innovation, which may 
affect community or organizational members‘ adoption decisions (Rogers, 2003). Therefore, social 
system characteristics also influence individuals‘ perceptions of an innovation. Peer influence and 
consensus in horizontal network structures and authoritative bodies in vertical network structures 
tend to determine adoption decisions. As well, the degree of similarity (referred to as ―homophily‖) 
of socioeconomic, cultural, or professional backgrounds between individuals, groups, or 
organizations influences the adoption. Furthermore, an individual who is perceived to be an ―opinion 
leader‖ is also able to influence other individuals‘ attitudes and behaviors. Opinion leaders can help 
raise awareness about innovations and lend them credibility (Weiner et al., 2006). Robertson (1967) 
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suggested introducing an innovation less to the masses and more to opinion leaders, since the average 
person is likely to be affected more strongly by social pressures, group associations, and the attitudes 
of opinion leaders than the direct use of media. Similarly, Valente and Davis (1999) introduced the 
implementation of the opinion leader model by selecting the opinion leader as the first adopter. This 
approach would accelerate the adoption rate in a social system. 
Innovation Process in an Organization 
 The innovation model developed by Rogers provides a linear process of innovation. The 
process includes 1) agenda setting, which is the process by which organizational members identify 
important problems and search for innovations to address the problems; 2) matching, which is the 
stage at which the decision to adopt or not adopt is made according to the extent that the innovation 
is matched to organizations‘ needs and capacities; 3) restructuring or redefining positions or the 
adaptation process, which is the step in which organizational members are becoming skillful, 
consistent, and committed in their use of an innovation; 4) clarifying, which is the step in which the 
innovation is put into more widespread use in an organization to enable the adopters to have a clear 
meaning of the innovation; and 5) routinizing, the final stage where the innovation becomes 
incorporated into the regular activities of the organization (Rogers, 2003; Weiner et al., 2006).  
Characteristics of Innovation 
Although the characteristics of innovations help to explain adoption decisions, studies of the 
association between innovation characteristics and innovation adoption at the organizational level are 
quite limited  (Damanpour & Schneider, 2008; Jerayaj et al., 2006). According to Rogers (2003), 
there are five attributes of innovations that influence the adoption decision and are reflected by 
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individuals or adoption units‘ perceptions: relative advantage, compatibility, complexity, trialability, 
and observability. These characteristics can be considered as ―secondary attributes‖ of innovation 
since they are qualities perceived by the senses and may be differently estimated by different 
recipients. The classification of innovation and the determination of adoption will be based on 
perception.  
Relative Advantage  
Relative advantage refers to the degree to which an innovation is perceived as superior or 
advantageous to current practice. It is typically viewed in economic terms of cost-benefit or cost-
effectiveness while social prestige factors, convenience, and satisfaction are also considered for 
measuring advantage. Such attribute is sometimes also regarded as perceived usefulness of the 
innovation (Tung et al., 2008). Innovation that has a clear advantage will be more easily adopted and 
implemented (Greenhalgh, Robert, Bate, Macfarlan, & Kyriakidou, 2005; Rogers, 2003). A decision 
to adopt is more likely when an organization has the capacity to manage downside risk or has a past 
history or propensity to take risks or when medical practitioners believe that innovation is 
advantageous. On the other hand, technical uncertainty negatively contributes to adoption of 
innovation (Hillman & Schwartz, 1985; Roth, Panzano, Crane-Ross, Massatti, & Carstens, 2002; 
Smythe, 2002). Insufficient information about an innovation provokes uncertainty among adopters 
about the risk from innovation adoption. Therefore, another important element of diffusion to be 
considered is information. Informational advantage of clinical group practice was found to hasten the 
adoption of innovations (Escarce et al., 1995). Relative advantage is one of the attributes usually 
found to be a significant contributing factor for innovation adoption in the field of health services 
research (Aubert & Hamel, 2001; Hung et al., 2010; Jerayaj et al., 2006; Scott et al., 2008).  
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Compatibility  
 Compatibility refers to the degree to which an innovation is perceived as being consistent 
with existing values, beliefs, past experiences, and needs of potential users. Innovation that fits with 
adopters‘ needs, values, and norms is more rapidly adopted (Rogers, 2003). Knudsen et al. (2003) 
reported that compatibility, as measured by an organization‘s rule orientation, presence of an 
employee assistance program, and mechanization, is associated with the adoption of drug testing 
modeling. A similar result was confirmed by Tung et al. (2008), who showed that perceived 
compatibility had a strong positive influence on the intention to adopt an electronic logistics 
information system in Taiwan‘s medical industry. In the context of organization, the extent that an 
innovation is compatible with past experience may be especially relevant because the uncertainty due 
to the change in organizational behavior is small for organizational members and the technology does 
not disturb the environment, values, and work habits of the professionals (Aubert & Hamel, 2001; 
Meyer et al., 1997). Nevertheless, a review of predictors of innovation adoption presented by Jerayaj 
et al. (2006) argued that compatibility is one of the worst predictors of IT adoption by organizations.  
Complexity  
 Complexity refers to the degree to which an innovation is perceived as difficult to understand 
and use. Simpler or even equally simple innovations spread faster than complicated ones (Rogers, 
2003). Some innovation researchers define this attribute as perceived ―ease of use,‖ in order to 
hypothesize its relationship with innovation adoption in the same direction as other attributes (Aubert 
& Hamel, 2001; Carter & Belanger, 2005; Tung et al., 2008). Ease of use is among the most 
frequently used predictors of IT adoption at the individual level. However, the research evidence 
supporting an association between complexity and innovation adoption is not conclusive. For 
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example, Hung et al. (2010) found that complexity is negatively associated with a hospital‘s adoption 
of a CRM system, although the relationship is not statistically significant. Similarly, Damanpour and 
Schneider (2008) reported that perceived complexity did not provide any significant contribution to 
innovation adoption.   
Trialability  
  Rogers (2003) defined trialability as the degree to which an innovation may be experimented 
with on a limited basis. The ability to try an innovation on a partial basis reduces uncertainty among 
individuals who are considering it for adoption, since the innovation can be learned by doing. 
However, health services researchers that consider trialability as an independent variable are very 
rare. Additionally, some of the empirical literature provides mixed results of the contribution of 
trialability to innovation adoption (Ducharme et al., 2007; Scott et al. 2008).   
Observability 
 According to Rogers (2003), observability refers to the extent that an innovation gives visible 
results. Innovations that generate benefits visible to intended adopters get adopted more rapidly 
because such visibility stimulates peer discussion of a new idea. Scott et al. (2008) found that 
observability of the benefits of the Heart Health Kit (HHK) was associated with physicians‘ intention 
to use the innovation. Grilli and Lomas (1994) stated that complexity, trialability, and observability 
together accounted for almost half of the variance in the adoption of clinical guidelines among 
physicians. However, unlike perceived relative advantages, compatibility, and complexity, 
observability has not usually been investigated, or, if so, has not been found to be a significant 
determinant of innovation adoption in health services research (Marshall, 1990; Meyer et al., 1997). 
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Some other constructs seem to have overlapping definitions with observability. Moore and Benbasat 
(1991) introduced ―demonstrability‖ and ―visibility‖ as additional factors influencing the acceptance 
and use of an innovation. These concepts were later used by Argarwal and Prasad (1997); Carter and 
Belanger (2005); Hsu, Lu, and Hsu (2007); and Compeau, Meister, and Higgins (2007) to predict 
adoption at the individual level.  
 Accordingly, innovation characteristics can be used for the prediction of the degree to which 
an innovation is ready for adoption. The innovations that are perceived to be more advantageous, 
compatible with users‘ socio-cultural backgrounds, easily comprehended, able to be experimented 
with before adoption, and able to generate visible results are likely to be adopted rapidly. However, a 
caution should be made when considering the predictive model of innovation adoption in regard to 
the research findings that use innovation characteristics as determinants. Several studies tended to 
capture the relationship of those predictors and individuals‘ ―intention to use‖; thus, the predictors 
may not have a true association with actual adoption. A study of the adoption of information 
technologies confirmed that innovation characteristics, as informed by other research such as 
determinants of intention to adopt, did explain acceptance behavior (Agarwal & Prasad, 1997). 
Organizational Innovativeness 
 Up to the present, many innovation studies focused on organizational innovativeness, with an 
attempt to distinguish the characteristics of the adopters versus the non-adopters, with the emphasis 
on a stage model in which methodologies directly imitated the individual-level innovativeness 
studies (Greenhalgh et al., 2005; Rogers, 2003). Some generalized determinants of organizational 
innovativeness have been suggested in the literature. For example, size of organization is consistently 
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found to have a positive contribution to innovativeness (Damanpour & Schneider, 2008; Hikmet et 
al., 2008; Hung et al., 2010; Kaluzny et al., 1974; Kimberly & Evanisko, 1981; Moch & Morse, 
1977; Naranjo-Gil, 2009).   
 In determining organizational innovativeness, the influence of organizational attributes on 
adoption was studied extensively (Rye & Kimberly, 2007). However, most studies using organization 
structural characteristics similar to Rogers‘ perspective as predictors of organizational innovation 
adoption were conducted during the late 1960s to 1980s (e.g., Hage & Aiken, 1967; Hage & Dewar, 
1973; Kaluzny et al., 1974; Meyer & Goes, 1988; Moch & Morse, 1976), while there is hardly any 
literature addressing these constructs in the current time. In addition, there seems to be no specific 
standardized measures for these variables (Kimberly & Cook, 2008). Organization characteristics, 
which could determine organizational adoption as suggested by Rogers (2003), comprise five internal 
(or structural) attributes: centralization, formalization, complexity, interconnectedness, and slack of 
resources.  
Centralization  
 Concentration of power in organization systems, as an indication of centralization, refers to 
the degree to which important decisions generally are made by administrators alone rather than by 
people throughout the organization (Rogers, 2003). Centralization plays an important role in 
determining an organization‘s adoption of innovation. In a meta-analysis by Damanpour (1991), 
centralization was consistently found to negatively contribute to innovation adoption in 
organizations. This finding could be due to the domination of the system by a few strong leaders who 
influence others‘ opinions (Rogers, 2003). Although centralization has usually been found to be 
negatively associated with innovativeness (Kimberly & Cook, 2008; Mellor & Mathieu, 1999), it was 
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found to associate positively for some types of innovations while inhibiting that of others (Kimberly 
& Evanisko, 1981; Moch & Morse, 1977; Rogers, 2003; Rye & Kimberly, 2007).   
Complexity  
 Complexity, according to Rogers (2003), is the extent to which an organization‘s members 
have a relatively high level of knowledge and expertise. Complexity is usually measured by the 
members‘ range of occupational specialties and their degree of professionalism. Hence, some 
innovation researches use specialization, functional differentiation, or professionalism in a similar 
sense as complexity (Damanpour & Gopalakrishnan, 1998; Kimberly & Cook, 2008; Kimberly & 
Evanisko, 1981; Moch & Morse, 1977). Organizations with more specialists may be expected to 
adopt more innovations. (Moch & Morse, 1977). However, while prevalence of specialization is 
generally assumed to correlate with the tendency of organizational members to embrace innovation, 
not every innovation will always be adopted in highly specialized organizations. Innovations may be 
adopted at different rates, and adoption even among specialists depends on the type of innovation and 
whether it is compatible with the specialists‘ own interests and needs. For example, Kimberly and 
Evanisko (1981) found that specialization and functional differentiation is positively associated with 
hospital adoption of technical innovation but not administrative innovation. Additionally, functional 
differentiation was found to facilitate adoption of innovation that is compatible with the needs of 
health care specialists (Moch & Morse, 1977) and was also found to be the strongest determinant of 
innovation adoption in several studies, as indicated by Damanpour (1991). Structural complexity was 
also found to positively relate to organizational innovation in some studies (Balridge & Burnham, 
1975; Damanpour & Schneider, 2008); however, Damanpour and Schneider (2008) found that 
structural complexity had a positive impact only on the initiation phase of adoption.  
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Formalization  
Formalization reflects the emphasis on organizational members‘ following rules and 
procedures. In other words, formalization measures the degree to which an organization is 
bureaucratic (Rogers, 2003) or the extent that an organization is run by rules and procedures 
(Kimberly & Cook, 2008). Formalization is usually found to be negatively associated with innovative 
behavior (Rye & Kimberly, 2007). Although relatively little empirical evidence is available that 
presents an association between formalization and innovation adoption, the degree of formalization 
was found as a primary predictor of innovation in hospitals (Kaluzny et al., 1974).  
Some studies argued that formalization might have a positive impact on innovativeness at the 
organizational level. Johnson et al. (1998) explored the indirect impact of formalization on perceived 
organizational innovativeness through role conflict, role ambiguity, and communication quality. 
They found that the influence of formalization on role conflict and role ambiguity was negative, but 
formalization exerted a positive effect on communication quality, which led to organizational 
innovativeness (Johnson et al.). Mellor and Mathieu (1999) found that formalization positively 
associated with local innovation.  
Interconnectedness  
 Interconnectedness is the degree to which the units in a social system are connected by an 
interpersonal network (Rogers, 2003). Internal and external communication among healthcare 
practitioners allows the flow of innovative ideas within and across organizations. Thus, this variable 
is assumed to be positively associated with organizational innovativeness (Rogers, 2003; Rye & 
Kimberly, 2007). Kimberly‘s empirical study about organizational structure that would provide 
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communication channels found that internal mechanisms that allow information about technological 
innovation to enter the organization (e.g., presentation by outside speakers to meetings of the hospital 
staff) facilitates innovation adoption (1978). Additionally, external communication achieved through 
practitioners‘ involvement in professional associations positively affected all phases of the 
innovation adoption process (Damanpour & Schneider, 2008). Ducharme, Knudsen, Roman, and 
Johnson (2007) investigated the impact of organizations‘ exposure to innovation on their adoption 
decisions. They found that the adoption of treatment innovation is a function of organizational 
participation in clinical trails, together with organizational resources and stage of the diffusion 
process.   
Organizational Slack 
 Organizational slack is the degree to which unencumbered budget, finance, human, and 
information resources are available to an organization (Rogers, 2003; Kimberly & Cook, 2008). 
Resources slack in an organization could be one of the supporting reasons explaining a positive 
relationship between organization size and innovativeness, since larger organizations tend to have 
more slack resources compared to smaller ones (Nystrom, Ramamurthy, & Wilson, 2002; Rogers, 
1998; Rye & Kimberly, 2007). In addition, organizational physical resources, such as adequacy of 
office and other physical space, availability of staff, and adequate use of computers, has been used as 
a measure for organizations‘ readiness for organizational change, which influences the 
implementation of innovations (Kimberly & Cook, 2008). 
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Environmental Influences 
Widely used to explain the readiness for an innovation‘s being adopted and the readiness of 
organizational structures to adopt an innovation as portrayed in this chapter, the domain of diffusion 
of innovation perspective appears to imply environmental impacts on organizational adoption. Since 
units of adoption are part of a social system in which the information about an innovation is delivered 
via communication channels, the theory‘s definitions of some constructs (e.g., innovation‘s 
observability, resources obtained from external sources (organizational slack), and organization‘s 
external interconnectedness) could serve as links to environmental and institutional influences on 
adoption decision making. Rye and Kimberly (2007) demonstrated the importance of connections 
among adopting organizations as facilitators of adoption. And, of course, individuals within networks 
contribute to organizational-level decision making.  
Innovation adoption also varies across location of organization and nature of community in 
which an organization is located (Kaluzny et al., 1970; Knudsen et al., 2003). Some studies on 
innovation adoption compared the adoption rate between organization located in urban and rural 
areas. Hospitals located in metropolitan areas were found to have greater rate of adoption (Follan, 
1987; Kaluzny et al., 1970; Kaluzny et al., 1974) and those located in the Northeastern states have 
greater rates of implementation of innovative health care services (Kaluzny et al., 1970). 
Contextual characteristics are also claimed to exert institutional influences on innovation 
adoption in many studies. Hospitals located in the areas with higher rates of innovation adoption 
were more likely to adopt and implement managerial innovation (Walston & Kimberly, 2001; Young 
et al., 2001). In addition, economic pressure, demand uncertainty, and market concentration are 
usually considered to be correlated with organizations‘ decisions to adopt an innovation (Escarce et 
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al., 1995; Naranjo-Gil, 2009; Walston & Kimberly, 2001). Interestingly, Marathe, Wan, Zhang, and 
Sherin (2007) and Naranjo-Gil (2009) consistently found that adopters were more sensitive to 
environmental factors than to organizational factors. 
Innovation Adoption and Organizational Performance  
 In general, organizational effectiveness or performance is the joint product of both the 
organization and its environment (Damanpour & Gopalakrishnan, 1998; Naranjo-Gil, 2009). 
Organizations innovate with the intention to improve or, at least, maintain their level of performance 
(Damanpour & Schneider, 2008; Wang & Shyu, 2009).  
Innovation was also considered an intervention variable in a recent study of performance 
improvement in nursing homes. A new principle for nursing practice adopted in nursing homes was 
found to be related to improvement of nurses‘ behaviors. Furthermore, the advantages of the 
innovation may lead to sustainability of the practice (Kovach et al., 2008). Similarly, Projogo and 
Sohal (2003) found that TQM leads to good quality performance. 
Although limited studies have been conducted to investigate the extent that innovations, both 
administrative and technological, contribute to better quality of care or services in the health care 
setting, all of the research findings concluded that innovation adoption and organizational 
innovativeness positively contributed to organizational performance (Devaraj & Kohli, 2003; 
Leidner, Preston, & Chen, 2010; Naranjo-Gil, 2009; Oliver & Antonio, 2009). In addition, in order to 
capture the impact of an innovation on performance, it is necessary that the ―actual‖ implementation 
of the innovation be taken into account (Devaraj & Kohli, 2003; Walker, Damanpour, & Devece, 
2010). 
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Analytical Framework and Hypotheses Generation 
Considering the extent that a hospital‘s innovation adoption decision is contingent on its 
environment, whereas its structural characteristics would facilitate the adoption and implementation 
of HIV ambulatory services quality improvement, this study applied a Context-Design-Performance 
framework for indicating a hypothesized relationship between the study variables. For the purpose of 
this study, the implementation of the HIVQUAL-T model is defined as the hospital actual practice on 
performance measurement and quality improvement in HIV clinical services delivery. Subsequently, 
organizational performance would require evidence to be collected upon which the assessments can 
be based. 
The Context-Design-Performance Framework 
 Most studies have focused on the relationship between environmental and organizational 
variables or between organizational and performance variables, yet the linkages among all three sets 
of variables have not been much investigated. Keats and Hitt (1988) introduced a conceptual 
framework for a model construction from general concepts that viewed organization as an open 
system that is influenced by environment (context), process (organizational characteristics), and 
outcome (performance), while strategic management perspective puts an emphasis on organizational 
strategies (Wan & Wang, 2003). Derived from contingency and strategic management perspectives, 
the context-design-performance (C-D-P) framework has been employed as a systemic model of the 
environment and organization interface and their associations to performance outcome.  
 According to Wan and Wang (2003), an organization‘s strategy is expected to be consistent 
with both its external environment and its core capabilities. Organizations perform activities within 
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an environmental context by obtaining inputs from the environment, responding to its demands, and 
offering their services or products. The adoption of innovation thus could be viewed as 
organization‘s response to its external environment (Damanpour & Schneider, 2008; Pierce & 
Delbecq, 1977). In the same way, internal organizations‘ structure, capabilities, and strategies should 
be associated with their performance.  
 Using the context-structure-performance framework, Lin and Wan (1999) found that 
contextual factors such as market competition, tax status, and network age contribute to the 
implementation of organizational strategies, while the strategies are positively correlated with 
structural design. Wan and Wang (2003) reported that the number of affiliated physicians, profit 
margin, and network size positively influence integrated health care network (IHN) performance. 
Marathe et al. (2007) applied a similar conceptual framework and found that contextual and 
organizational structural factors could determine community health centers‘ technical and cost 
efficiency.  
 The use of this type of framework requires a consideration of time-ordered processes when 
organizations‘ decision-making and practices (operational design) do not occur simultaneously with 
the existence of the social system (context) and organizational structure (structural design) and when 
organizational performance is regarded as the outcome of the system. Thus, in this study context, the 
adoption of the HIVQUAL-T model implies not only a single point of time that hospitals put the 
HIVQUAL-T performance measurement software into practice but also the extensiveness of the 
implementation: adopting the model, measuring performance, and eliminating deficiencies by 
executing quality improvement actions, which is expected to result in better quality HIV ambulatory 
service delivery.  
  
35 
 The context-design-performance framework would serve to link contextual components that 
were hypothesized to stimulate adoption at the hospital level, theoretical constructs and observable 
indicators of organizational structural characteristics as organizational structural design components, 
extensiveness of the HIVQUAL-T model adoption as organizational operational design (or strategy) 
component, and organizational performance of HIV service delivery.  
 Although organizational structure, as a construct, is also expected to account for a 
performance dimension as it might directly affect performance level not only through organizational 
operations, the absence of relevant prior research on a direct relationship between structural 
characteristics and health care organizations‘ performance has challenged this study. In addition, the 
design of organizational structure was found to have only a limited effect on performance level 
(Child, 1972). Wan (2003) conducted a study of nursing care quality in nursing homes by pointing up 
the direct relationship between nursing homes‘ structure components on nursing care adequacy, 
which was considered a process component, and between nursing care adequacy and nursing care 
quality. Therefore, the relationships between organizational structure and organizational practice and 
between organizational practice and organizational outcome were proven to be linearly ordered, 
which might imply indirect effects of structure to performance (Wan, 2003). Also, Hendrick (2003) 
proposed that it is not easy to evaluate the complex and contingent relationship of structural variables 
such as size and complexity with process and performance variables. Since the main purpose of this 
study is to establish and validate theoretical constructs and measures in the boundary of diffusion of 
innovation theory and the extent to which adoption would help to improve organization performance, 
direct causal effects from structural characteristic constructs derived from the theory to the 
performance measures were not taken into account.  
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 In addition, this study considered possible impacts of individuals‘ perceptions on innovation 
characteristics as predictors of innovation adoption since the implementers of HIVQUAL-T model 
implementation are practitioners who are embedded in hospitals and have certain degree of 
participation in hospitals‘ decision making to adopt the model.  
 Figure 1 provides the conceptual model of contextual, organizational structural, and 
innovation attribute predictors of HIVQUAL-T Model Adoption and their contributions to HIV 
clinical services performance based on the context-design-performance framework. 
 
 
Figure 1. Conceptual Framework for studying HIVQUAL-T Model Adoption and HIV 
Ambulatory Services Performance 
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Hypotheses Generation  
 By using the C-D-P framework, the study investigates the relationships of the variables on 
three levels: 1) perceived innovation characteristics as predictors for hospitals‘ extensive degree of 
innovation adoption; 2) organization structural characteristics as predictors for hospitals‘ extensive 
degree of innovation adoption; and 3) extensive degree of innovation adoption as predictor of HIV 
clinical service performance. The conceptual framework presents major hypothesized relationships as 
follows: 
H1: Innovation characteristics (relative advantage, compatibility, simplicity, trialability, and 
observability) as perceived by hospital practitioners are positively associated with the hospitals‘ 
extensiveness of HIVQUAL-T model adoption. 
H2: Organizational structural characteristics (centralization, complexity, formalization, 
interconnectedness, and organizational slack) are associated with the hospitals‘ extensiveness of 
HIVQUAL-T model adoption. The detailed hypotheses are given as follows: 
H2a: Hospitals that have a greater degree of complexity are more likely to have a greater 
degree of extensiveness of HIVQUAL-T model adoption. 
H2b: Hospitals that have a greater degree of centralization are more likely to have a greater 
degree of extensiveness of HIVQUAL-T model adoption. 
H2c: Hospitals that have a greater degree of interconnectedness are more likely to have a 
greater degree of extensiveness of HIVQUAL-T model adoption. 
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H2d: Hospitals that have a greater degree of formalization are less likely to have a greater 
degree of extensiveness of HIVQUAL-T model adoption. 
H2e: Hospitals that have greater resources are more likely to have a greater degree of 
extensiveness of HIVQUAL-T model adoption. 
H3: Hospitals that adopt and implement HIVQUAL-T model more extensively are more 
likely to perform better in HIV clinical services delivery.  
Chapter Summary 
 This chapter presents a review of Everett M. Rogers‘s so-called ‗diffusion of innovation‘ 
theory and its implications to health services research. Research employing this perspective 
demonstrates the application mostly in terms of the adoption behavior in regard to the impact of 
perceived innovation attributes and organization structural characteristics. However, limited studies 
were found to document the extent to which the adoption of innovation could contribute to the 
desired outcomes related to better organizational performance.  
 Innovation adoption could be considered as organizational decision-making that might not 
depend only on individuals‘ perceptions and organizational structure but also on environmental 
influences within organizations‘ contexts. The constructs proposed by this perspective such as 
observability, interconnectedness, and organizational slack, as well as observed contextual 
characteristics such as location and adoption rate in the areas, seem to imply the flow of information 
and resources from external environments or social systems into organizations. As such, an 
application of the context-design-performance (C-D-P) framework in this study allowed an 
assessment of HIVQUAL-T model implementation by postulating the impact of contextual 
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characteristics and hospitals‘ structural design on their operational design, namely, the extensiveness 
of the HIVQUAL-T model adoption and the contribution of the adoption to hospitals‘ HIV 
ambulatory services performance. The direct causal effects were hypothetically drawn from 
organizational context and structural design to operational design, and from operational design to 
performance. However, the direct causal effects from structural characteristic constructs derived from 
the diffusion of innovation theory to organizational performance were not taken into account due to 
the absent of relevant prior research and the fact that the purpose of this study was to validate and 
examine the relationships among theoretically informed constructs. 
 
 
CHAPTER THREE: METHODOLOGY 
The two-fold purpose of this study in accordance with the research questions is to investigate 
the extent to which perceived innovation characteristics and organization structural characteristics 
contribute to the variation of hospitals‘ HIVQUAL-T model adoption. The relationship between 
variation in hospitals‘ HIVQUAL-T model adoption and better HIV clinical care performance was 
then examined. This chapter discusses the analytical method employed in the study. The study design; 
data sources; measurements of exogenous, endogenous, and control variables; and hypothesized 
structural relations among the study variables in multivariate statistical analysis are presented. 
Study Design  
This study applied a natural experimental design since the HIVQUAL-T program was 
initiated and implemented by Thailand‘s Ministry of Public Health with no intervention introduced 
by the researcher. This is a lagged cross-sectional study that compared hospitals‘ performance after 
an adoption period. The dependent variable, extensiveness, has a longitudinal characteristic since the 
use of the HIVQUAL-T software and the implementation of quality improvement are not a single 
event. Hospitals generally start conducting performance assessment by a year‘s end and use the 
assessment results to inform quality improvement implementation in  later years. The sample 
universe is public hospitals that never participated in the HIVQUAL-T program pilot implementation 
during the years 2003–2005.  The unit of analysis is hospital. 
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Sources of Empirical Data 
Two main data sources were used in this study: 1) HIVQUAL-T performance measurement 
dataset and 2) an online survey of HIVQUAL-T model adoption.  
HIVQUAL-T Performance Dataset 
The HIVQUAL-T performance dataset is a national dataset created by the Bureau of AIDS, 
Tuberculosis, and Sexually Transmitted Infections (BATS), Ministry of Public Health, Thailand, and 
was provided by BATS‘ Quality Improvement of HIV/AIDS Treatment and Care Program in May 
2010. The dataset contains HIV ambulatory services performance information obtained from the 
adopting facilities from the pilot implementation period (2003–2005) to the national scaling up 
period (until present). The most recent information was the performance measurement results as of 
the year 2009. This dataset was used to identify hospitals‘ HIV ambulatory services performance, 
which was reported with core and additional HIV care and treatment indicators developed by the 
program. Generally, BATS uses this information to report the trends of provincial, regional, and 
national-level HIV care performance improvement to the public through the program‘s website: 
http://www.cqihiv.com.  
Survey Instrument 
A survey instrument was developed to obtain essential information about 1) HIV 
practitioners‘ perceptions toward the characteristics of the HIVQUAL-T model, 2) structural 
characteristics of hospitals, and 3) the implementation of quality improvement projects regarding 
performance measurement results in the respondents‘ facilities. The survey questionnaire contains 
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measures of five constructs of HIV care practitioners‘ perceived innovation characteristics and five 
constructs of hospitals‘ structural characteristics. All perceived innovation characteristics and some 
structural characteristics were measured using a five-point Likert Scale, representing a range of 
attitudes from strongly disagree to strongly agree. The questionnaire requested the respondents to 
present the information on organization structural characteristics in ordinal-polytomous or 
continuous questions, depending on each variable.  
Since most of the variables in this study were latent constructs, for which validity of scales of 
measurement is usually a concern, this study attempted to apply pre-tested constructs from previous 
empirical studies employing innovation or other compatible perspectives wherever possible. Thus, 
most survey questions were based on the measurements created and validated by similar studies. 
Where no validation of measurement of any constructs was presented, the indicators for those 
constructs were developed with the application of the concepts and definition given in the relevant 
literature.  
The study‘s survey questionnaire was developed with revisions from health services research 
experts and HIV care specialists. Since this study was conducted in Thailand, the questionnaire was 
translated into the Thai language and was reviewed and pilot-tested in order to ensure content 
validity. The drafts of online questionnaires were purposively sent to HIV care practitioners in 30 
hospitals, in the region with high and low adoption rates. Twenty hospitals completed the 
questionnaires. The pilot respondents were further asked to provide comments on any questions, 
statements, and the organization of the questionnaire. Only a few items were reported to be 
ambiguous and were later removed from the actual version while some more detailed questions about 
the implementation of quality improvement were added as suggested by the respondents. 
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Measurement of Endogenous Variables 
Extensiveness of HIVQUAL-T model Adoption 
Innovation adoption researchers typically measure adoption dichotomously; nevertheless, 
many innovations are not discrete variables and can vary from one setting to the next, reflecting 
different combinations of administrative structure and process (Walston & Kimberly, 2001). The 
adoption variable in this study seemed to have such characteristics, since the innovation: 
‗HIVQUAL-T‘ model has two main implementation components. Thus, HIVQUAL-T model 
adoption was defined as the extensiveness of the practice. As mentioned earlier, it was expected that 
hospitals conducted the performance assessment by a year-end, following the performance results; 
they would implement the quality improvement activities in the later years. This study, hence, 
allowed for possible lagged practices of the HIVQUAL-T model implementation. Extensiveness of 
HIVQUAL-T adoption was categorized into three ordinal levels, including hospitals that did not 
adopt the model during the years 2007–2008, indicating that they were non-adopters; hospitals that 
reported performance measurement results using HIVQUAL-T software in either year 2007 or 2008 
but did not report quality improvement practices, indicating initial adoption of the model with no 
extension of use; and hospitals that reported performance measurement results using HIVQUAL-T 
software and reported quality improvement practices in the years 2008–2009, indicating extensive 
adoption of a whole model. The information in determining hospitals‘ extensiveness of HIVQUAL-T 
adoption was the combination of the HIVQUAL-T software utilization reported in the HIVQUAL-T 
performance dataset and the hospitals‘ implementation of quality improvement projects indicated by 
survey respondents.  
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HIV Ambulatory Services Performance 
 HIV ambulatory services performance was considered as a latent endogenous variable. The 
study applied the concepts of HIV clinical care according to the national guidelines by measuring the 
presence or absence of six domains of baseline HIV clinical care for outpatients provided by 
hospitals. There were eight indicators that were measured by percentage of eligible patients receiving 
the following services: 1) CD4 screening; 2) Viral load screening; 3) ARV treatment; 4) primary PCP 
prophylaxis; 5) primary Cryptococosis prophylaxis; 6) Tuberculosis screening; 7) Sexually 
transmitted diseases screening; and 8) PAP smears for women. This information was obtained from 
BATS‘ HIVQUAL-T Performance Dataset.  
Measurement of Exogenous Variables 
Perceived Innovation Characteristics 
Perceived innovation characteristics—including relative advantages, compatibility, 
complexity, trialability, and observability—were considered as latent constructs. The concepts for 
measuring perceived innovation characteristics were mainly obtained from Rogers (2003) and were 
illustrated in Tornatzky and Klein‘s meta-analysis of innovation characteristics in relation to 
innovation adoption (1982). The study used and adjusted the measurement that was developed by 
Moore and Benbasat in 1991 and re-validated by Agarwal and Prasad in 1997 and Compeau, Meister, 
and Higgins in 2007. These measurements have been used in many innovation studies to determine 
individual-level adoption of information technology (Hsu et al., 2007; Yang, Yu, & Yang, 2009). 
After pilot testing and adjustment, each construct contained four items, which asked the respondents 
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to express their agreements according to a five-point Likert scale ranging from strongly agree to 
strongly disagree. 
Relative Advantages: 
Relative advantage was measured by the degree to which the HIVQUAL-T model is 
perceived to be better than other performance measurement and quality improvement methods. The 
items used in the questionnaire asked the respondents whether prior to the adoption decision the 
HIVQUAL-T software and the quality improvement implementation were perceived 1) to be more 
convenient; 2) to be less time consuming; 3) to result in better HIV services quality; and 4) to help 
obtain and maintain hospital accreditation status more easily. 
Compatibility: 
Compatibility was measured by the degree to which the model can be easily applied to 
routine practice and the degree to which the model needs special training and consumes time for 
implementation. The items used in the questionnaire asked the respondents whether prior to the 
adoption decision the HIVQUAL-T software and the quality improvement implementation were 
perceived 1) to be compatible with all aspects of the HIV clinic‘s work; 2) to be compatible with the 
clinic‘s needs for assessing performance; 3) to fit with the way they like to work; and 4) to be 
compatible with their past experience. 
Complexity:  
Complexity, or simplicity, as used in this study, was measured by the degree to which the 
HIVQUAL-T software is easy to use and the degree to which QI practice is easy to implement. The 
items used in the questionnaire asked the respondents whether prior to the adoption decision 1) the 
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concept of the HIVQUAL-T model was easy to learn; 2) how to use the performance measurement 
software was easy to remember; 3) the software was user friendly; and 4) QI proposal was easy to 
write. 
Trialability: 
Trialability was measured by the degree to which a certain period of time is allowed for 
trying and making decisions for the adoption. The items used in the questionnaire asked the 
respondents whether prior to the adoption decision they received 1) enough supports for trying the 
software; 2) proper chances to try the software; 3) enough opportunity to try the software; and 4) 
enough time to use and see the benefits of the software. 
Observability: 
Observability was measured by the degree to which HIV clinic staffs are able to investigate 
the implementation results among pilot hospitals before making a decision for adoption. The items 
used in the questionnaire asked the respondents whether prior to the adoption decision they perceived 
that 1) observing the use of the software in other hospitals is easy; 2) they had opportunities to see 
the model implemented in pilot sites; 3) the benefits of using the model was visible to them; and 4) 
seeing pilot sites implementing the model made them feel confident about putting it into use.  
Organization Structural Characteristics 
 Some organization structural characteristics are also latent variables. Using the same 
instrument as was used in measuring perceived innovation characteristics, this study asked the 
respondents about organizations‘ internal attributes, including centralization, complexity, 
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formalization, interconnectedness, and organizational slack. However, the measurements of these 
organizational characteristics varied across each study and across theories that were used for 
determining adoption behavior. As noticed by Rye and Kimberly (2007), some variables were used 
as measures of constructs in various categories. The only constructs, to the researcher‘s knowledge, 
whose measurements have been validated were centralization and formalization developed by Aiken 
and Hage (Aiken & Hage, 1966; Hage & Aiken, 1967), tested by Dewar, Whetten, and Boje (1980), 
and adjusted by Auh and Menguc (2007). Nevertheless, these measurements were not found to have 
been applied in innovation research. Therefore, this study attempted to apply and adjust the 
measurements of centralization and formalization of Aiken and Hage, Dewar et al., and Auh and 
Menguc to fit with the study context and develop the measures for complexity, interconnectedness, 
and organizational slack by applying the concepts from other relevant studies. As well as the 
measurements of perceived innovation attributes, all constructs of organization structural 
characteristics had four measurement items. The items could be in the form of statements that asked 
the respondents to express their level of agreement in a five-point Likert scale or in the form of 
ordinal-polytomous questions, for non-perception information.  
Centralization: 
Centralization is the extent to which important decision generally are made by a few people 
rather than organizational members throughout the facility (Kimberly & Evanisko, 1981; Rogers, 
2003). In the study context, centralization is the extent to which HIV clinical staffs can make a 
decision pertaining to the HIV clinic‘s activities.  The statements asked the respondents whether their 
HIV clinics‘ decision making considered 1) their participation regarding the adoption of new 
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programs; 2) their willingness to implement any voluntry initiatives; 3) the approval from the 
supervisors as most important; and 4) only higher position staff‘s agreement. 
Formalization: 
Formalization is usually considered the extent to which HIV clinic staff follow a formal 
organizational chart and the extent to which their work deviates from a written job description or 
organization rules (Auh & Menguc, 2007; Kaluzny et al., 1974; Rogers, 2003). The statements asked 
the respondents the extent that 1) they strictly followed treatment protocol; 2) the employees had to 
conforms to rules; 3) they could work beyond job description; and 4) they could work beyond their 
typical practices. 
Complexity: 
Organizational complexity reflects functional differentiation and specialization (Damanpour, 
1991, Kimberly & Cook, 2008; Moch & Morse, 1977). Thus, it can be generally measured by the 
number of departments in a hospital, the number of hierachical levels in the organizational chart, and 
the number of specialized professional categories (Damanpour & Gopalakrishnan, 1998; 
Subramanian & Nilakanta, 1996). This study measured organizational complexity prior to the 
adoption regarding 1) the extent that hospitals could provide complex services, which was 
represented by the type of hospitals; 2) whether the hospitals had medical specialists; 3) whether the 
hospitals had internal medicine physicians serving HIV clinics; and 4) whether the hospitals had 
pediatricians serving HIV clinics. 
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Interconnectedness: 
Interconnectedness implies both internal and external integration in this study and was 
measured by the extent to which HIV clinics collaborated with other departments and other 
organizations (Kimberly, 1978). This study measured interconnectedness as the frequency of HIV 
care practitioners‘ attending HIV forums or meetings at the 1) hospital; 2) provincial; 3) regional; 
and 4) national levels. 
Organizational Slack: 
Organizational slack refers to the amount of financial support and the frequency of technical 
support available for implementing the innovation (Kimberly & Cook, 2008; Subramanian & 
Nilakanta, 1996). This study measured organizational slack by asking the respondents whether prior 
to the adoption their HIV clinics 1) had several sources of budget available; 2) had enough physical 
space for HIV peer group activities; 3) had difficulty in getting financial support from the hospital 
board; and 4) had enough computers in the clinics.  
Control Variables 
Applying only theoretical constructs from Rogers‘ diffusion innovation perspective may 
provide limited capability of explaining the variance in the operational design and performance 
variables of the study. Thus, organizational attributes and contextual factors commonly used in other 
organization performance research, such as rate of adoption in the area, size, and HIV care 
practitioners‘ workloads (HIV patients-to-staff ratio), were also included in the analysis as control 
variables to examine alternative plausible explanations for the variability in hospital performance.  
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Rate of Adoption in the Area: 
 Implementation of the HIVQUAL-T model at the national level usually requires coordination 
at provincial and regional levels. At the regional level, coordination from the Offices of Disease 
Prevention and Control (DPC) is significant in distributing the information and providing training 
facilities for the HIVQUAL-T program. This study considered the regional adoption rate in 2007 
among 12 DPC offices nationwide.  
Rate of adoption could be also considered as organizational cohesion (Rye & Kimberly, 2007) 
to the environment. In this study, it was measured by the percentage of hospitals that adopted the 
HIVQUAL-T model by the year 2006, which would lead to the adoption decision-making in 2007 or 
2008. Hospitals that are located in the regions with high adoption rates would have more 
opportunities to receive information about the use of HIVQUAL-T software and QI implementation, 
particularly those in the regions with many pilot implementers and trainers. Additionally, the rate of 
adoption in the area could entail institutional effect of organizations‘ decision making to adopt the 
innovation. 
Hospital Size: 
 Hospital size was measured by number of beds in the year 2007, implying the capacity of the 
facility.  
Workload: 
Similarly, HIV care practitioners‘ workloads could affect innovation adoption in the 
sense that the practitioners who already had high workloads might not be willing to spend time 
for other activities in additional to providing the care. More specifically, the HIVQUAL-T 
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software requires the practitioners‘ time and effort to conduct self-assessment, write QI 
proposals, and implement QI activities. Workload was claimed to be one potential barrier to 
implementing the HIVQUAL-T model among the adopters. This study measured HIV clinic 
workload as nurse-to-patient ratio, by dividing number of nurses by the number of patients as of 
the year 2007. Number of full-time nurses was assigned a value of one for each full time person 
and number of part time nurses was assigned the value of 0.2 for each part-time person. Unlike 
other studies, this study did not count the unit of nurse staffing in the form of full-time equivalent 
staff for the reason that 1) full-time nurses in this setting refers to nurses who are responsible for 
only HIV clinic practice, regardless of the number of hours they work each day in a week, and 2) 
part-time nurses in this setting refers to nurses who are mainly working in different departments 
but have responsibility to assist HIV clinics at least once a week (mostly on the day that the 
clinic provides medication). For example, hospital A is serving 500 HIV patients, with 2 full-
time nurses in its HIV clinic and 2 part-time nurses. Hospital B is serving 300 HIV patients, with 
2 full-time nurses and 1 part-time nurse. Therefore, hospital A‘s HIV clinic‘s workload = 
(2+0.4)/500=0.0048 while hospital B‘s HIV clinic‘s workload = (2+0.2/300)=0.0073. High 
nurse-to-patient ratio implies smaller workload. The operationalization of the study variables is 
presented in Table 1.  
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Table 1. Operational Definitions of the Study Variables and Coded Items 
Variables Operational Definitions Sources 
Endogenous Variables  
Extensiveness 0 = No adoption; 1 = Adoption of PM; 2 = Adoption of PM+QI Survey/ 
HIVQUAL-T 
results 
HIV Services 
Performance 
CD4 
ARV 
PCP 
Crypto 
TB 
Syphilis 
PAP 
VL 
The extent that a hospital can provide eligible patients with clinical services measured 
by: 
- Percentage of eligible patients receiving CD4 screening  
- Percentage of eligible patients receiving ARV treatment 
- Percentage of eligible patients receiving PCP prophylaxis 
- Percentage of eligible patients receiving Crypto prophylaxis 
- Percentage of eligible patients receiving TB screening 
- Percentage of eligible patients receiving Syphilis screening 
- Percentage of eligible patients receiving Cervical cancer screening 
- Percentage of eligible patients receiving Viral load screening 
Survey/ 
HIVQUAL-T 
results 
   
Exogenous Variables  
Latent 
Construct 
Question Items  
(5-points Likert Scale: 5 = Strongly agree ~ 1 = Strongly disagree) 
 
 
Centralization      The degree to which HIV care practitioners can make independent decision pertaining  
                             HIV Clinic‘s activities: 
Survey 
 
Central 1 I usually participate in any decisions regarding the adoption of new programs such as 
HIVQUAL-T. 
Central 2 My willingness to implement any voluntary initiatives was considered important for 
HIV clinic‘s decision making. 
Central 3 There could be little action here until the head of department or medical supervisor 
approves a decision. 
Central 4 Even small matters had to refer to someone higher up for a final answer. 
   
Formalization      The degree to which HIV care practitioners‘ follow a formal organization chart and a  
                             written job description: 
Survey 
Formal 1 My decision on serving HIV patients usually followed the written statement protocol. 
Formal 2 The employees here were constantly being checked for rule violations. 
Formal 3 I usually worked beyond the formal job description. 
Formal 4 Under an agreement with physicians, nurses could provide care beyond their typical 
nursing practices when necessary. 
   
Organizational Slack   The amount of  uncommitted resources devoted to an HIV clinic: Survey 
Slack 1 There were several sources of budget available for our HIV clinic. 
Slack 2 The hospital had enough space available for HIV peer support group activities. 
Slack 3 We usually had difficulty in getting supporting money from the hospital board. 
Slack 4 We had enough number of computers in our HIV clinics. 
   
Relative Advantage  The degree to which the HIVQUAL-T model is perceived to provide more benefits       
                                  than do other quality management models: 
Survey 
Advantage 1 I thought that using HIVQUAL-T software would be more convenient than other 
performance assessment methods. 
Advantage 2 I thought that using HIVQUAL-T software would be less time-consuming than other 
performance assessment methods. 
Advantage 3 I believed that the HIVQUAL-T model would result in better HIV service quality. 
Advantage 4 I believed that the HIVQUAL-T model would help the hospital to obtain and maintain 
Hospital Accreditation (HA) status more easily. 
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Variables Operational Definitions Sources 
Observability       The degree to which information and results of the HIVQUAL-T implementation in  
                             other hospitals are available for the implementer in an HIV clinic: 
Survey 
Observe 1 It was easy for me to observe other hospitals using HIVQUAL-T software in their HIV 
clinics. 
Observe 2 I had plenty of opportunities to see the HIVQUAL-T model being implemented in 
pilot sites. 
Observe 3 It was visible how other hospitals using the model can improve their service in quality. 
Observe 4 Seeing pilot sites implementing HIVQUAL-T model made me feel more confident in 
putting it into use in my HIV clinic. 
   
Trialability           The degree to which HIV practitioners can try the HIVQUAL-T software before  
                             making decisions to adopt: 
Survey 
Trial 1 There were enough technical supports to help me try the HIVQUAL-T software. 
Trial 2 I was able to properly try it out. 
Trial 3 I had a great deal of opportunity to try the software. 
Trial 4 I was permitted to use HIVQUAL-T software on a trial basis long enough to see what 
it could do. 
   
Simplicity            The degree to which the HIVQUAL-T model is easy to understand and implement: Survey 
Simple 1 Learning the concepts of the HIVQUAL-T model was easy for me. 
Simple 2 It was easy for me to remember how to use HIVQUAL-T software. 
Simple 3 I believed that HIVQUAL-T software was user-friendly. 
Simple 4 I believed that I would not have difficulties in writing a QI proposal. 
   
Compatibility      The degree to which the HIVQUAL-T model fit well with hospital‘s values and needs Survey 
Compat 1 I thought that the HIVQUAL-T model was compatible with all aspects of the clinic‘s 
work. 
Compat 2 I believed that the HIVQUAL-T model was compatible with the clinic‘s needs of 
assessing HIV clinical care performance. 
Compat 3 I thought that using HIVQUAL-T model fill well with the way we like to work. 
Compat 4 I felt that HIVQUAL-T model was compatible with my past experience. 
   
Complexity          The level of expertise and knowledge of hospitals‘ personnel   Survey 
Complex 1 Hospital category: 4 = University Hospital; 3 = Regional Hospital; 2 = General 
Hospital; 1 = Military Hospital, Community Hospital, or Other 
Complex 2 Availability of medical specialists in hospitals: 1 = Yes; 0 = No 
Complex 3 Availability of internal medicine physicians in hospitals: 1 = Yes; 0 = No 
Complex 4 Availability of pediatrician in HIV clinic: 1 = Yes; 0 = No 
   
Interconnectedness   The extent to which HIV care practitioners collaborate with other departments or  
                                  other organizations in order to share information related to HIV care 
Survey 
Intercon 1 Frequency of HIV practitioner‘s attendance to HIV forums of meetings at hospital or 
community level  
Intercon 2 Frequency of HIV practitioner‘s attendance to HIV forums of meetings at provincial 
level 
Intercon 3 Frequency of HIV practitioner‘s attendance to HIV forums of meetings at regional 
level 
Intercon 4 Frequency of HIV practitioner‘s attendance to HIV forums of meetings at national 
level 
 (6 = Once a month; 5 = Every two months; 4 = Every three months; 3 = Every six 
months; 2 = Once a year; 1 = Less than once a year) 
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Variables Operational Definitions Sources 
Control Variables 
Age Age of HIV care practitioners (years) 
1 = 18-25; 2 = 26-35; 3 = 36-45; 4 = 46-55; 5 = 56 or older 
Survey 
WorkHIV Years of experience in HIV clinic Survey 
RegRate Rate of adoption in region HIVQUAL-T 
results 
Size The number of beds Survey 
Workload Nurse-to-patient ratio in HIV clinic Survey 
Position 1 = Nurse; 2 = Physicians; 3 = Pharmacist; 4 = Pharmacy Technician;  
5 = Public Health Technician; 6 = AIDS Coordinator; 7 = Other 
Survey 
Data Collection 
With the cooperation from BATS, the URLs for the online questionnaire were accessible for 
all public hospitals in Thailand via two channels, including 1) BATS‘ website 
(http://www.cqihiv.com), which stated the needs for evaluating the HIVQUAL-T program, and 2) e-
mail messages sent from BATS to Disease Control and Prevention (DPC) regional offices and to 
HIVQUAL-T coordinators or implementers nationwide.  
Subsequently, the follow-up started one week later by telephone calls to HIV practitioners 
who were reported to be responsible for implementing performance measurement and quality 
improvement in hospitals‘ HIV clinics, in order to confirm that they had received the links. This 
follow-up focused only on the hospitals that met the inclusion criteria. In the cases for which the 
practitioners had not yet received any contacts from BATS, the researcher verbally explained the 
purpose of the study and asked whether the practitioners would voluntarily give responses. If so, the 
practitioners were asked to provide updated e-mail addresses to receive the links. All e-mails sent to 
the respondents included the introductory letter and the letter of consent approved by the University‘s 
Institutional Review Board. The second follow-up was done in the fourth week. The lists of all public 
hospitals in Thailand and their phone numbers were obtained from the National Health Security 
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Office (HNSO)‘s telephone directory. This online survey was conducted and stored by using an 
online database service provider. 
Due to the length and the requirements for some complex information regarding numbers of 
patients and service performance, the respondents were allowed access to uncompleted 
questionnaires to add or update their information, in order to provide the most accurate numbers as 
possible. Therefore, duplicated hospital identification numbers could occur in the dataset. Only the 
most recent information indicated by the latest access dates of each hospital ID was retained. 
Methods of Analysis 
Structural Equation Modeling 
The contribution of innovation adoption to HIV clinical services performance in this study 
was modeled using the structural equation modeling method (SEM). Structural equation modeling is 
an extension of regression methods with causal specifications among the study variables. Its process 
contains two steps: validating the measurement model and fitting the structural model (Wan, 2002). 
SEM provides several advantages for analyses, compared with other multivariate analysis methods. 
First, SEM can deal with latent constructs derived from theoretical perspectives. It can take into 
account variables that have multiple related dimensions or observed indicators and uses confirmatory 
factor analysis as the tool to examine the measurement model of the constructs. Second, SEM allows 
building an analytical (causal) model with multiple exogenous and endogenous variables, for both 
observable and unobservable (latent) indicators. Third, it is the only methodology that is capable of 
examining relationships between latent variables (Byrne, 2001). Fourth, SEM allows the flexibility to 
incorporate measurement models, program impacts, and covariate effects simultaneously. Fifth, SEM 
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could incorporate measurement sub-models for different assessment levels (Baydar, Jamila, & 
Webster-Stratton, 2003). This study includes a number of latent constructs.  Thus, the SEM is a 
powerful tool for measuring the relatedness among indicators associated with common constructs 
and then investigating the effects of exogenous latent variables on multiple endogenous variables.  
Confirmatory Factor Analysis 
 In social sciences, most theories and models are formulated in terms of hypothetical 
concepts that are not directly measurable but are often measured by a number of indicators. In 
SEM, one generates a measurement model in order to describe how well the observed indicators 
could serve as a valid measurement instrument for a latent variable (Wan, 2002).  In order to 
examine whether a theoretical latent construct can serve for common variations among its 
observed indicators, a confirmatory factor analysis (CFA) is used. It is essential that 
measurement models be validated before being included into a causal analysis in a structural 
model. The study includes multiple measurement models for both exogenous and endogenous 
variables that are to be validated using the CFA method. Both SEM and CFA were performed 
using AMOS 18.0. The measurement model of endogenous variable ―HIV clinical services 
performance‖ proposed by this study is presented in Figure 2.   
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Figure 2. A Hypothesized Measurement Model of Endogenous Variable "HIV Ambulatory 
Services Performance" 
Figure 3 presents the generic covariance structural model hypothesizing the impacts of 
HIV practitioners‘ individual characteristics indicated by five latent exogenous variables 
including relative advantage, compatibility, simplicity, trialability, and observability, on 
extensiveness of the HIVQUAL-T model implementation, with workload and rate of adoption in 
the area as control variables.  
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Figure 3. A Hypothesized Covariance Structural Model for the Impacts of Perceived Innovation 
Attributes on Extensiveness of HIVQUAL-T Model Adoption 
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From Figure 4, the proposed covariance structural model of innovation adoption and 
hospital‘s HIV ambulatory services performance presented the relationship between five latent 
exogenous variables of organization structural characteristics—centralization, complexity, 
formalization, interconnectedness, and organizational slack—and the endogenous variable, 
extensiveness of the HIVQUAL-T model implementation. In this model the relation of extensiveness 
of the HIVQUAL-T model implementation to hospital‘s HIV ambulatory services performance is 
also proposed, with additional control variables, including rate of adoption in the area, workload, and 
size.  
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Figure 4. A Hypothesized Covariance Structural Model for the Impacts of Organization 
Structural Characteristics on Extensiveness of HIVQUAL-T Model Adoption and HIV 
Ambulatory Services Performance 
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Model Validation 
 After performing model specification using the structural equation modeling approach, it is 
necessary to assess model fit in order to ensure the appropriate interpretation of the theoretical 
framework. (Wan, 2002). 
Criteria for Determining the Overall Fit of the Model 
Several statistical means can evaluate how well a specified model fits the data. Consulting 
multiple fit statistics would help in considering different aspects of fit (Roberts, 1999). This study 
uses the Bentler (1990) chi-square statistics, the Jörekog & Sorbom (1986) Goodness-of-fit Index 
(GFI) and Adjusted Goodness-of-fit Index (AGFI), Steiger and Lind (1980) Root Mean Square Error 
of Approximation (RMSEA), the Normed Fit Index (NFI), Tucker-Lewis Index (TLI), and Hoelter‘s 
critical N (Albright & Park, 2009; Roberts, 1999; Wan, 2002). The criteria for determining the 
overall model fit, using the rule of thumb, as described by Wan (2002), are as follows: 
2 likelihood ratio (2 /df): A chi-square likelihood ratio tests the null hypothesis that the 
sample covariance matrix is drawn from a population characterized by the hypothesized covariance 
matrix. A small ratio indicates a better fit; however, there is no consistent standard for what is 
considered an acceptable model. This study considers the relative chi-square < 4 to indicate 
acceptable fit.  
GFI & AGFI: The goodness of fit index is a measure of amount of variances and covariances 
jointly accounted for by the model. The adjusted goodness of fit index is an alternate GFI in which 
degrees of freedom are taken into account. Larger values indicate better fit. This study considers the 
GFI and AGFI > 0.9 to indicate acceptable fit.  
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RMSEA: The root mean square error of approximation measures the lack of fit compared to 
the saturated model. RMSEA of 0.05 indicates a good fit while RMSEA of 0.08 or less indicates an 
acceptable fit. 
NFI: The Normed Fit Index is the difference between the independence model and the 
identified model‘s chi-square divided by the chi-square for the independence model. NFI > 0.90 
indicates an acceptable fit while NFI > 0.95 indicates a good fit. 
TLI: The Tucker-Lewis Index, in addition to NFI, takes into account the penalty for adding 
parameters. TLI > 0.95 indicates a good fit.  
HOELTER: The Hoelter‘s critical N indicates the largest sample size for which one would 
accept the hypothesis that a model is correct. At 0.05 level of significance, a value equal to or greater 
than 200 is required.  
Improving the Model Fit 
To improve the goodness of the model fit, three steps would be applied in the analyses: 1) 
eliminating observed variables or indicators that do not have statistically significant contributions to 
the latent or endogenous variables; 2) removing indicators with small factor loadings; and 3) 
allowing measurement errors of observed variables to be correlated as suggested by the modification 
indices. 
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Chapter Summary 
 This is a lagged cross-sectional study that uses two main datasets, including Thailand‘s 
national HIV service performance data and survey data. The survey instrument developed in this 
study contains three major parts: 1) respondents‘ perceptions on innovation characteristics; 2) 
hospitals‘ structural characteristics, and 3) information on the implementation of the HIVQUAL-T 
model. Most measurements for latent constructs were validated by previous studies and some 
measurements were developed and based on the concepts proposed by other relevant studies. Data 
collection resulted in a 54% response rate. The hypothesized covariance structural models for the 
impacts of perceived innovation characteristics on extensiveness of adoption and the impacts of 
organization structural characteristics on extensiveness of adoption with the contributions to hospitals‘ 
HIV ambulatory services performance were presented. 
 
 
CHAPTER FOUR: STUDY RESULTS 
 This chapter presents information about the characteristics of the respondents, characteristics 
of the sample hospitals, and descriptive statistics of each variable. The study was conducted in two 
major steps for data analysis, including confirmatory factor analysis for examining construct validity 
and structural equation modeling for examining the relationship between exogenous and endogenous 
variables, using AMOS 18.0. The study results as well as their interpretations are illustrated.  
Data Preparation  
Sample Data 
The main dataset for this study was the data obtained through a random survey of 828 public 
hospitals operating under Thailand‘s Ministry of Public Health. This dataset excluded 58 pilot sites 
that participated in the HIVQUAL-T pilot implementation period as of 2005. Finally, from 770 non-
pilot hospitals nationwide, a total of 381 hospitals responded, accounting for the response rate of 
50%. This dataset was merged with the performance measurement results dataset in order to 
distinguish the adopters from non-adopters and identify their level of HIV ambulatory services 
performance. 
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Data Cleaning 
 This study examined two covariance structural models; thus, after the data cleaning process, 
two datasets were applied for the analyses: 1) a dataset for investigating only the impacts of 
innovation attributes perceived by HIV care practitioners on adoption-implementation behavior and 
2) a dataset for investigating the impacts of hospitals‘ structural characteristics on adoption-
implementation behavior and the implication of the extensiveness of the adoption on hospitals‘ HIV 
ambulatory services performance.  
 Missing data was handled by listwise deletion, which resulted in dropping 29 observations 
from the individuals‘ perceived innovation attributes dataset and 66 observations from the hospitals‘ 
structural characteristics dataset, of the original 381 observations, resulting in 352 completed 
observations for the former dataset and 315 observations for the latter. There seemed to be several 
missing items among the non-adopters who reported no experience of any types of performance 
measurement activities. Accordingly, they might not have been able to provide information regarding 
the performance measurement results and were thus removed from the dataset.  
Descriptive Statistics 
Characteristics of the Sample 
Since this is an organizational-level study, the survey respondents were considered as 
representative of each hospital. All respondents are HIV care practitioners who reported being 
responsible for performance assessment activities in each hospital‘s HIV clinic. The majority of the 
respondents (79.8%) were nurse practitioners, while 1.1% were physicians, 1.1% were pharmacists, 
1.8% were pharmacy technicians, 2.1% were public health officers, and 14.2% were HIV/AIDS 
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coordinators. Most of the respondents were 36–45 years old (48.0%), followed by 46–55 years old 
(26.7%), 26–35 years old (21.4%%), 18–25 years old (3.6%), and 55 years old or above (0.4%).  
However, due to data collection problems pertaining to the internet-based survey, 70 
respondents (19.9%) reported the inability to access the last page of the survey questionnaire, where 
they were asked about demographical characteristics. This, unfortunately, resulted in the failure to 
include demographical characteristics of the respondents into the structural model to investigate the 
impact of perceived innovation attributes on hospitals‘ adoption behavior. Thus, only the constructs 
of innovation attributes perceived by these HIV care practitioners and two control variables, rate of 
adoption in the region and HIV clinic workload, were included in the covariance structural model.  
According to the hospitals‘ structural characteristics dataset, of 315 hospitals that reported 
their performance results, community hospitals accounted for a majority of the observations (85.7%), 
followed by general hospitals (7.2%), and regional hospitals (4.1%). The proportion of each type of 
hospital in the study was quite consistent with the proportion in the entire population (of 828 
hospitals; 88.0% are community hospitals, 8.6% are general hospitals, and 3.0% are regional 
hospitals). Additionally, the proportion of the sample observation by disease prevention and control 
(DPC) region is not much different from the entire population, as shown in Table 2, indicating that 
this sample could be a representative for explaining the adoption behaviors of Thai hospitals 
nationwide. 
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Table 2. Percentage of Hospitals by Type and DPC Region 
Category Percent of sample (n=315) Percent of population (N=828) 
Type   
Regional Hospitals 4.1 3.0 
General Hospitals 7.2 8.6 
Community Hospitals 85.7 88.4 
DPC Region   
DPC 1 3.8 3.7 
DPC 2 5.4 5.7 
DPC 3 9.5 9.2 
DPC 4 5.4 6.9 
DPC 5 8.3 9.4 
DPC 6 14.6 14.0 
DPC 7 9.5 11.1 
DPC 8 6.3 5.0 
DPC 9 4.8 5.6 
DPC 10 11.4 11.6 
DPC 11 14.6 9.1 
DPC 12 6.3 8.8 
 
Adoption Behavior 
 According to BATS‘ performance measurement results as of 2008, 632 hospitals (76%) had 
reported the use of the HIVQUAL-T software. However, it was found that there were 276 adopters 
(87.6%) out of 315 hospitals in the study dataset. This different proportion was due to missing data 
from several non-adopters who could not provide the information regarding hospitals‘ performance, 
as mentioned above. Among the adopters, 58 hospitals (18.4% of total respondents) reported using 
only the HIVQUAL-T software in either 2007 or 2008 or both, with no quality improvement 
activities in 2008 or 2009. Two hundred eighteen hospitals (69.2% of total respondents) reported the 
full use of the HIVQUAL-T model while 39 hospitals (12.4% of total respondents) reported no 
experience in implementing the model either in 2007 or 2008. The descriptive statistics for hospitals‘ 
adoption behavior is presented in Table 3. 
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Table 3. Extensiveness of the HIVQUAL-T Model Adoption of the Study Samples 
Extensiveness 
Dataset 1 (n=352) Dataset 2 (n=315) 
Frequency Percent Frequency Percent 
No adoption 54 15.3 39 12.4 
PM adoption 68 19.3 58 18.4 
PM adoption + QI 
implementation 
230 65.3 218 69.2 
Total 352 100 315 100 
Descriptive Statistics of Latent Endogenous, Latent Exogenous, and Control Variables 
 Table 4 presents the means and standard deviations for latent constructs for perceived 
innovation attributes and control variables. Each construct has four indicators, mostly with minimum 
value of 1 or 2 and maximum of 5. The indicators for the construct: Relative Advantage have 
relatively larger mean values than other constructs, which could imply that hospitals may generally 
view the HIVQUAL-T model to be more advantageous than other performance measurement 
methods. Particularly, the item Advantage 1 stated that using the HIVQUAL-T software was more 
convenient than other methods (mean = 4.08, Std. = 0.710) and the item Advantage3 stated that the 
respondents believed that the model would result in better HIV services quality (mean = 4.14; Std. = 
0.638).  
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Table 4. Descriptive Statistics for Variables for Perceived Innovation Attributes Model (n=352) 
Key Variables Minimum Maximum Mean 
Standard 
deviation 
Extensiveness of adoption 0 2 1.50 0.747 
Relative advantage     
Advantage1 2 5 4.08 0.710 
Advantage2 1 5 3.90 1.773 
Advantage3 2 5 4.14 0.638 
Advantage4 1 5 3.96 0.761 
Observability     
Observe1 1 5 3.18 0.808 
Observe2 1 5 2.44 1.053 
Observe3 1 5 3.53 0.769 
Observe4 1 5 3.38 0.892 
Trialability     
Trial1 1 5 3.30 0.974 
Trial2 1 5 3.03 1.083 
Trial3 1 5 2.90 1.049 
Trial4 1 5 2.83 1.046 
Simplicity     
Simple1 1 5 3.72 0.684 
Simple2 1 5 3.68 0.709 
Simple3 1 5 3.63 0.781 
Simple4 1 5 3.30 0.812 
Compatibility     
Compat1 1 5 3.74 0.719 
Compat2 2 5 3.91 0.617 
Compat3 2 5 3.70 0.716 
Compat4 2 5 3.73 0.682 
Control variables     
Workload 0.00 1.20 0.033 0.074 
Rate of adoption (RegRate) 0.30 0.72 0.243 0.230 
Note: See Table 1. for detailed questions for each item. 
 
From Table 4, an average workload, which was quantified by nurse-to-patient ratio, is 0.033 
with 0.074 standard deviation. Smaller values indicate larger workload. A value of zero in nurse-to-
patient ratio were found in the facilities that reported neither full-time nor part-time nurses serving in 
HIV clinics. It could be interpreted that some hospitals may assign their nurses to serve in several 
clinics with no specific responsibility for HIV care and they had already too much of a workload to 
take care of only HIV patients. Alternatively, it could imply that the hospitals may not have a 
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dedicated unit specifically for serving HIV patients. In this sense, hospitals‘ dedication to HIV care 
could be reflected by whether a hospital assigns an adequate number of personnel to serve HIV 
patients. 
Descriptive statistics for the second dataset, as illustrated in Table 5, shows the average 
percentage of each item measuring the endogenous variable, HIV ambulatory services performance. 
Most items, except CD4, have a wide variation from zero to 100% of eligible patients receiving the 
services. As CD4 screening is considered as the frontline service to be provided to any HIV patients, 
the average percentage of patients receiving CD4 screening across hospitals is higher than other 
service categories (mean = 94.30, Std. = 11.792). A low average percentage of eligible patients 
receiving the services is found in cervical cancer screening for women (PAP smear) and viral load 
screening (mean = 65.19 and 62.99, respectively), implying that these two services may not be 
common among hospitals. A low PAP smear rate could be due to the procedure of the test, which 
may be undesirable under Thailand‘s cultural context. Low viral load screening could be due to its 
relatively high cost, which could be an important barrier in many poor-resource settings. 
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Table 5. Descriptive Statistics for Variables for Structural Characteristics Model (n=315) 
Key Variables Minimum Maximum Mean 
Standard 
deviation 
HIV ambulatory services 
performance     
CD4 16.00 100 94.30 11.792 
ARV 0 100 73.74 23.819 
PCP 0 100 89.34 20.580 
Crypto 0 100 83.54 24.221 
TB 0 100 80.35 29.243 
Syphilis 0 100 92.10 20.190 
PAP 0 100 65.19 38.493 
VL 0 100 62.99 31.768 
Extensiveness of adoption 0 2 1.57 0.703 
Centralization      
Central1 1 5 3.84 0.992 
Central2 1 5 3.95 0.804 
Central3 1 5 3.38 1.072 
Central4 1 5 3.95 0.894 
Formalization     
Formal1 1 5 3.96 0.752 
Formal2 1 5 3.93 0.916 
Formal3 1 5 1.95 0.884 
Formal4 1 5 2.86 0.899 
Complexity     
Complex1 1 3 1.18 0.483 
Complex2 0 1 0.20 0.401 
Complex3 0 1 0.26 0.441 
Complex4 0 1 0.19 0.393 
Interconnectedness     
Intercon1 0 6 2.90 1.393 
Intercon2 0 6 2.84 1.175 
Intercon3 0 6 2.84 1.265 
Intercon4 0 6 2.03 1.076 
Organizational Slack     
Slack1 1 5 2.83 1.020 
Slack2 1 5 3.00 1.236 
Slack3 1 5 3.06 1.054 
Slack4 1 5 3.56 1.138 
Control variables     
Hospital size 10 1000 99.13 160.650 
Workload 0.00 1.20 0.032 0.764 
Rate of adoption (RegRate) 0.03 0.72 0.248 0.228 
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Table 5 also presents average values of the endogenous variable Extensiveness of adoption 
as consistent with the values from the first dataset (mean = 1.57, Std. = 0.703 and mean = 1.50, Std. 
= 0.747, respectively). Likewise, the average values of rate of adoption and workload are 0.248 and 
0.032 with 0.072 and 1.20 standard deviations, respectively, which are close to the values presented 
in the other dataset. Most items measuring organization structures also have similar average values 
within the same construct. However, the construct ‗Formalization,‘ which contains two items with 
reversed values (Formal3 and Formal4) shows inconsistent mean values as compared to two other 
items (mean = 1.95 and 2.86 for Formal3 and Formal4, respectively).  
It was noticed that hospital size varies largely from 10 beds to 1000 beds with an average of 
99.13 beds and a standard deviation of 160.650. This variation could depend on the type of hospital. 
Generally, regional hospitals could have at least 500 beds while general hospitals could have at least 
120 beds. Community hospitals‘ size could vary from 10 to 150 beds.  
Confirmatory Factor Analysis 
 The study applied three sets of constructs: 1) HIV ambulatory services performance; 2) 
organization structural characteristics; and 3) perceived innovation attributes. All items measuring 
the constructs are theoretically based and are illustrated in several measurement models. 
Confirmatory factor analyses were employed for examining construct validity. The items with 
insignificant factor loadings were removed from the measurement models while measurement errors 
were allowed to be correlated in order to obtain models that fit well with the data. The revised 
measurement models were later used to draw and examine hypothesized relationship among the 
exogenous and endogenous variables, using the structural equation modeling method.  
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HIV Ambulatory Services Performance 
 HIV ambulatory services performance is an endogenous latent variable that includes eight 
baseline HIV care and treatment indicators informed by the national guidelines for HIV clinical care 
and treatment and the HIVQUAL-T software. The eight items include CD4 counts screening (CD4); 
antiretroviral drug therapy for symptomatic patients or asymptomatic patients with CD4 ≤ 200 
cells/µL (ARV); primary Pneumocystis Pneumonia prophylaxis for patients with CD4 ≤ 200 cells/µL 
(PCP); primary Cryptococosis prophylaxis for patients with CD4 ≤ 100 cells/µL (Crypto); 
tuberculosis screening (TB); syphilis screening (Syphilis); pap smear for women (PAP); and viral 
load screening (VL). For the HIVQUAL-T model adopters, the HIV ambulatory services 
performance information was obtained from BATS‘ HIV care performance dataset while the survey 
items asked non-adopters to provide their performance results by using the same calculation 
algorithms as used by the software: number of patients who received the service divided by number 
of patients eligible to receive the service. All items were measured as percentage of eligible patients 
who had received these baseline services from hospitals‘ HIV clinics as of 2009. 
Correlation Analysis 
 A Pearson‘s correlation was performed in order to examine the association between each 
item in the construct. All items are correlated at < 0.05 level of significance. There existed a strong 
correlation between PCP and Crypto (r = 0.799), while VL had weak associations with most of the 
items.  
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Measurement Model of HIV Ambulatory Services Performance 
 The following diagram (Figure 5) with standardized regression weight illustrates the 
generic, one-factor measurement model of HIV ambulatory services performance, where the 
HIV Services Performance latent variable is manifested by eight observed variables. All factor 
loadings show C.R. > 1.96, indicating statistical significance. PCP and Crypto have large factor 
loadings of 0.92 and 0.83; thus, they appear to be the best indicators of HIV Services 
Performance. VL has relatively poor factor loading, suggesting that it may not be a good 
representation of HIV Services Performance, compared to other indicators. The model fit 
summary show a χ2 = 287.553 with 20 degrees of freedom, which results in χ2/df = 14.377         
(p < .000). In addition, the Goodness of Fit Index (GFI) and Adjusted Goodness of Fit Index 
(AGFI) are small (0.798 and 0.636, respectively) while the Root Mean Square Error 
Approximation (RMSEA) is .206, indicating that this measurement model is a poor fit and needs 
a modification. 
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Figure 5. A Generic Measurement Model of HIV Ambulatory Services Performance  
To improve the model performance, VL was removed from the model due to its poor factor 
loadings and explained variance. Besides, despite being the best indicators for HIV services 
performance, PCP and Crypto represent the same dimension of primary prophylaxis of opportunistic 
infections; additionally, as suggested by Pearson‘s correlation, they appear to be highly correlated (r 
= .799). Hence, for preventing possible multicollinearity issues and for data reduction, Crypto, whose 
variance is relatively less explained by the construct (R2 = 0.70) as compared to PCP, was removed 
from the model. A revised measurement model of HIV ambulatory services performance is presented 
in Figure 6 
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Figure 6. A Revised Measurement Model of HIV Ambulatory Services Performance 
 
 After removing Crypto, it appeared that TB became the best indicator for HIV Services 
Performance ( = 0.826), followed by CD4 ( = 0.687) and PCP ( = 0.582). Modification indices 
suggested that ARV is closely related to PCP and CD4, which, practically, could be because both 
ARV and PCP services provision generally follow CD4 cell counts as the main criteria to identifying 
eligible patients to receive the services. Additionally, the measurement errors for Syphilis and PAP 
were allowed to be correlated with moderate correlation value ( = 0.39). As a result, the model 
performance was improved considerably with a χ2 = 9.271 with 6 degrees of freedom, which results 
in χ2/df = 1.545 with p = .159, too large to reject the null hypothesis of a good fit. The GFI and AGFI 
of .990 and .965 are large, as well as NFI and TLI, which are close to 1 (.980 and .982, respectively). 
Additionally, RMSEA is significant (p = .042) with PCLOSE = .543. HOELTER is larger than 200 at 
the 0.05 level of significance (HOELTER = 427). These multiple goodness-of-fit indices confirmed 
that the measurement model fit quite well with the data and could represent a good measure for HIV 
  
77 
ambulatory services performance in Thailand‘s HIV care setting. Parameter Estimates for the 
indicators of HIV ambulatory services performance are presented in Table 6. 
Table 6. Parameter Estimates for the Indicators of HIV Ambulatory Services Performance 
 Generic Revised 
 
 
Items 
Standardized  
Regression 
Coefficients 
 
Critical Value 
Standardized  
Regression 
Coefficients 
 
Critical Value 
CD4 0.443 *6.337 0.687 <     > 
ARV 0.506 *7.934 0.360 *5.786 
PCP 0.920 *7.837 0.582 *8.550 
Crypto 0.835 *6.558 -- -- 
TB 0.540 *4.969 0.826 *9.612 
Syphilis 0.347 *4.997 0.341 *5.224 
PAP 0.349 *3.666 0.480 *7.222 
VL 0.236 *6.337 -- -- 
Goodness of Fit Statistics     
    χ2 287.533  9.271  
    Df 20  6  
    χ2/df (p-value)  14.377 (0.000)  1.545 (0.159)  
    GFI 0.798  0.990  
    AGFI 0.636  0.965  
    NFI 0.678  0.980  
    TLI 0.567  0.982  
    RMSEA 0.206  0.042  
Notes: -- Items were not included in the revised model. 
         <blank> indicates constrained items with a regression weight of 1. 
         *Critical ratio greater than 1.96 is considered statistically significant at the 0.05 level. 
 
Perceived Innovation Attributes 
 Perceived innovation attributes, according to the diffusion of innovation theory, include five 
constructs: Relative Advantage, Observability, Trialability, Simplicity, and Compatibility. This study 
validated five measurement models for the five constructs. Each construct contains four items 
measured in dichotomous or ordinal scales.  
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Correlation Analysis 
The results from Pearson‘s correlation showed that all items, both within and across 
constructs, were significantly correlated. Some items such as Advantage1 and Advantage2 (r = 0.70) 
and Trial2, Trial3, and Trial 4 (r > 0.80 < 0.90) were found to be strongly correlated, but the r-values 
were not yet high enough to ensure the multicollinearity problem. All items, thus, were retained, and 
the constructs were to be validated in the confirmatory factor analysis process.  
Measurement Models of Perceived Innovation Attributes 
The confirmatory factor analyses for the generic measurement models of the five constructs 
for perceived innovation attributes showed that all constructs were quite valid. The measurement 
model of observability ( 
Figure 7-C) indicated significant factor loadings of all items. The strongest indicator was 
Observe3 (whether it was visible to the prospect adopters how other hospitals using the model could 
improve their service quality), with standardized  = 0.73, R2 = 0.53. The model fit was obtained 
with χ2 = 7.154/2 df (p = 0.28), GFI and AGFI = 0.990 and 0.951, and RMSEA = 0.085. Simple2 
(whether it was easy to remember how to use the HIVQUAL-T software) appeared to be the best 
indicator for the construct ‗simplicity‘ (Figure 7-D), with standardized  = 0.91, R2 = 0.83. The 
model fit was acceptable with χ2 = 7.131/2 df (p= 0.028 ), GFI and AGFI = 0.990 and 0.952, and 
RMSEA = 0.086. Trialability ( 
Figure 7-E) was well represented by its four indicators. Trial3 (whether the prospective 
adopters had a great deal of opportunity to try the software) had the highest standardized factor 
loadings and variance explained by the construct ( = 0.96, R2 = 0.92). This measurement model fit 
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quite well with the data, with χ2 = 2.304/2 df (p = 0.316), GFI and AGFI = 0.997 and 0.983, and 
RMSEA = 0.021. These three models did not require further validation; thus, they were ready to use 
in the structural model of the impacts of perceived innovation attributes on extensiveness of 
adoption.  
 
Figure 7. The Five Measurement Models of Perceived Innovation Attributes 
 
Among the four items of relative advantage (Figure 7-A), Advantage2 (whether the 
HIVQUAL-T software seemed to be less time consuming than other performance measurement 
methods) appeared to be the best indicator ( = 0.85). The modification indices suggested allowing 
the measurement errors of Advantage3 (whether the HIVQUAL-T model was believed to result in 
better service quality) and Advantage4 (whether the HIVQUAL-T model was believed to help 
hospitals to obtain and maintain accreditation status) to be correlated; nevertheless, the model fit was 
satisfied by few criteria (χ2 = 10.995/1 df (p = 0.001), GFI and AGFI = 0.985 and 0.848, NFI = 
0.981, and RMSEA = 0.169. The measurement model of compatibility (Figure 7-B) was validated 
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with all items with large and statistically significant factor loadings. Compat3 (whether the 
HIVQUAL-T model was perceived to fit well with the way HIV care practitioners like to work) had 
the strongest factor loading on the construct ( = 0.92, R2 = 0.84). The measurement errors of 
Compat1 (overall compatibility) and Compat2 (whether the model was compatible with the needs for 
assessing performance) were moderately correlated (r = 0.40). The model fit statistics was acceptable 
with χ2 = 7.907/1 df (p = 0.05), GFI and AGFI = 0.989 and 0.890, NFI = 0.990, and RMSEA = 
0.140. Although the modification indices suggested more correlated errors for the models of relative 
advantage and compatibility, adding more parameters to be estimated would result in unidentified 
parameter estimates since the degree of freedom would be equal to zero. Therefore, further validation 
of these measurement models was not desirable. The detailed results of the validated models were 
presented in Table 7. 
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Table 7. Parameter Estimates for the Indicators of Perceived Innovation Attributes Constructs 
 Parameter Estimates Goodness-of-Fit Statistics 
 
Constructs/Items 
Standardized  
Factor 
Loadings 
Critical  
Value 
 
χ2/df 
 
p-value 
 
GFI 
 
AGFI 
 
RMSEA 
Relative Advantage   10.995/1 0.001 0.985 0.848 0.169 
Advantage1 0.818 <     >      
Advantage2 0.855 *14.426      
Advantage3 0.667 *12.258      
Advantage4 0.594 *10.724      
Compatibility   7.907/1 0.005 0.989 0.890 0.140 
Compat1 0.695 *16.105      
Compat2 0.723 <     >      
Compat3 0.916 *14.928      
Compat4 0.817 *14.496      
Observability   7.131/2 0.028 0.990 0.951 0.085 
Observe1 0.487 *7.150      
Observe2 0.662 <     >      
Observe3 0.728 *8.939      
Observe4 0.629 *8.589      
Simplicity   7.154/2 0.028 0.990 0.952 0.086 
Simple1 .797 *18.469      
Simple2 .910 <     >      
Simple3 .847 *20.107      
Simple4 .570 *11.478      
Trialability   2.304/2 0.316 0.997 0.983 0.021 
Trial1 .655 *14.737      
Trial2 .913 <     >      
Trial3 .961 *32.124      
Trial4 .898 *27.165      
Note: <blank> indicates constrained items with a regression weight of 1. 
         *Critical ratio greater than 1.96 is considered statistically significant at the 0.05 level.  
 
Organization Structural Characteristics 
 This study considered five dimensions of organization structural characteristics as predictors 
for organizational innovativeness, according to the diffusion of innovation theory. These internal 
attributes contained both subjective and objective (perception) indicators. The five structural 
characteristics included Centralization, Formalization, Complexity, Interconnectedness, and 
Organizational slack. Each construct had four measurement items. 
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Correlation Analysis 
 The results from Pearson‘s correlation showed that the items within the constructs, 
Centralization, Complexity, Interconnectedness, and Organizational Slack, were positively correlated 
at  > 0.05 level of significance. However, some items indicating formalization were negatively 
correlated, particularly the items with reversed coding. For example, Formal3 and Formal4 are 
negatively correlated with Formal1 and Formal2. These negative associations may contribute to the 
violation of construct reliability. Aside from these, there were no high correlations among the items; 
thus, multicollinearity among the indicators may not be an issue. The validity of all constructs could 
be examined by conducting confirmatory factor analysis.  
Measurement Models of Organization Structural Characteristics 
 Confirmatory factor analysis was performed to examine the construct validity of organization 
structural characteristics. Figure 8 presents the measurement models for organization structural 
characteristics. The measurement model of organization structural characteristics indicated 
significant factor loadings for all items. Figure 8-A presents a revised model of organizational 
Complexity. After allowing the measurement errors of complex 1 (level of services indicated by 
hospital type) and complex4 (whether the hospital had a pediatrician serving in the HIV clinic) to be 
correlated, an acceptable model fit was obtained with a χ2 of 2.585/1 df (p = 0.108), GFI and AGFI = 
0.996 and 0.959, and RMSEA = 0.71. Complex2 (whether the hospital had medical specialists 
working on-site in 2007) appeared to be the best predictor for complexity ( = 0.83), with 69% of 
variance explained by the construct. Likewise, the measurement model of Interconnectedness (Figure 
8-B) was well represented by its four indicators. Intercon2 (how frequently HIV care practitioners 
attend HIV forums or meetings at the provincial level) appeared to be the best predictor for 
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Interconnectedness ( = 0.87; R2 = 0.75). Correlated measurement errors for Intercon3 and Intercon4 
(frequency of attending HIV forums or meeting at regional and national level) improved the model fit 
with χ2 = 1.774/1df (p = 0.183), GFI and AGFI = 0.997 and 0.972, and RMSEA = 0.050. The four 
indicators of organizational slack (Figure 8-C) also presented statistically significant factor loadings. 
Slack4 had the highest standardized factor loading ( = 0.53). The measurement model of 
organizational slack fit well with the data without further validation.  
 
Figure 8. The Five Measurement Models of Organization Structural Characteristics 
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For the measurement model of Centralization (Figure 8-D), Central3 and Central4 were not 
statistically significant indicators, with C.R. < 1.96 and small standardized factor loadings ( = 0.115 
and 0.098, respectively). However, when Central3 and Cental4 were removed from the model, other 
indicators (Central1 and Central2) became insignificant. Interestingly, Formal3 and Formal4 had 
significant but negative factor loadings ( = -0.62 and -0.12, respectively) on the construct 
‗formalization‘ (Figure 8-E), which resulted in a violation to the assumption of measurement 
reliability. Therefore, all items could not be valid measures for Centralization and Formalization in 
this study context and were not included into the structural model. The detailed results of the 
validated measurement models are presented in Table 8. 
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Table 8. Parameter Estimates for the Indicators of Perceived Innovation Attributes Constructs 
 Parameter Estimates Goodness-of-Fit Statistics 
 
Constructs/Items 
Standardized  
Factor 
Loadings 
Critical  
Value 
 
χ2/df 
 
p-value 
 
GFI 
 
AGFI 
 
RMSEA 
Centralization
a 
  135.014/2 0.000 0.851 0.256 0.460 
Central1 .900 *2.490      
Central2 .724 <     >      
Central3 .115 1.849      
Central4 .098 1.577      
Complexity   2.585/1 0.108 0.996 0.959 0.071 
Complex1 .621 *9.776      
Complex2 .832 <     >      
Complex3 .745 *11.709      
Complex4 .692 *10.923      
Interconnectedness   1.774/1 0.183 0.997 0.972 0.050 
Intercon1 .554 *5.833      
Intercon2 .867 <     >      
Intercon3 .523 *5.732      
Intercon4 .287 *3.915      
Slack of Resources        
Slack1 .420 *3.597 2.778/2 0.249 0.996 0.978 0.035 
Slack2 .407 <     >      
Slack3 .469 *3.710      
Slack4 .527 *3.734      
Formalization
a 
  5.285/2 0.071 0.992 0.960 0.072 
Formal1 .266 *2.783      
Formal2 .508 <     >      
Formal3 -.618 *-2.425      
Formal4 -.124 -1.504      
Note: <blank> indicates constrained items with a regression weight of 1. 
          
a
Construct was not revised and included in further analysis. 
         *Critical ratio greater than 1.96 is considered statistically significant at the 0.05 level. 
 
Structural Equation Modeling 
Two covariance structural models were built for conduction path analyses in order to 
investigate the influences of perceived innovation attributes and organization structural 
characteristics on the implementation of the HIVQUAL-T model and the impacts of the 
implementation on hospitals‘ HIV ambulatory services performance.  
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Influences of Perceived Innovation Attributes on HIVQUAL-T Model Adoption 
 SEM using AMOS 18.0 was employed for examining the relationship between a set of 
perceived innovation attributes and hospitals‘ extensiveness of the HIVQUAL-T model 
adoption, as shown in Figure 9. In this model, the endogenous variable, extensiveness of 
adoption (Extensiveness), is an observed variable that is influenced by five perceived innovation 
attributes constructs. The constructs were represented as five validated measurement models of 
relative advantage (Advantage), observability (Observe), Simplicity (Simple), Trialability 
(Trial), and Compatibility (Compat), each composed of four indicators.  
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Figure 9. A Generic Covariance Structural Model of the Impacts of Perceived Innovation 
Characteristics on Hospitals‘ Extensiveness of the HIVQUAL-T Adoption 
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The path coefficients between perceived innovation attributes and extensiveness of adoption 
were estimated in order to examine the causal relationship among the set of exogenous variables and 
the endogenous variable. Table 9 illustrates standardized factor loadings, standardized path 
coefficients, and model fit statistics from the generic and revised covariance structural models. 
Parameter estimates from the generic model show that the path coefficients of Observability, 
Compatibility, and Trialability are not statistically significant (C.R. < 1.96 and p-value > 0.05), 
indicating that these three attributes did not contribute to HIV care practitioners‘ extensive 
implementation of the HIVQUAL-T model and were thus removed from the causal model. However, 
the level of significance of Advantage in the generic model was close to 0.05 (C.R. = 1.774); 
therefore it was retained in order to investigate its effect size in a less complex structural model. In 
addition, a measurement error (d3) of the construct Advantage appeared to be correlated with other 
measurement errors within the same construct, as well as other constructs; thus, the indicator 
Relative3 was removed from the model since it may not be a good measure for only a single 
construct.  
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Table 9. Parameter Estimates for the Analysis of Impacts of Perceived Innovation 
Characteristics on Extensiveness of HIVQUAL-T Model Adoption 
 Generic Revised 
Effect Standardized 
Coefficients 
Critical Value Standardized 
Coefficients 
Critical Value 
Advantage      on  Extensiveness 0.097 1.744 0.112 *2.060 
Observability  on Extensiveness 0.067 1.128 -- -- 
Trialability      on  Extensiveness 0.073 1.406 -- -- 
Simplicity       on  Extensiveness 0.115 *2.134 0.138 *2.551 
Compatibility on Extensiveness -0.052 -0.969 -- -- 
RegRate          on  Extensiveness 0.203 *3.980 0.209 *4.112 
Workload        on  Extensiveness -0.122 *-2.401 -0.124 *-2.385 
R
2 
0.091  0.097  
Goodness of Fit Statistics     
    χ2 867.560  91.381  
    df 224  31  
    χ2/df (p-value)  3.873 (0.000)  2.948 (0.000)  
    GFI 0.794  0.951  
    AGFI 0.747  0.913  
    NFI 0.805  0.926  
    TLI 0.827  0.927  
    RMSEA 0.090  0.074  
Note: -- Constructs were not included in the revised model. 
         *Critical ratio greater than 1.96 is considered statistically significant at the 0.05 level. 
 
The revised covariance structural model illustrated in Figure 10 presents statistically 
significant path coefficients of Simplicity and Relative Advantage (C.R. = 2.551 and 2.060, 
respectively), as well as the two control variables RegRate (C.R. = 4.112) and Workload (C.R. = -
2.385). Rate of adoption in the region wherein hospitals were located appeared to be the strongest 
predictor of the extensive implementation of the HIVQUAL-T model ( = 0.209), followed by 
perceived simplicity of the HIVQUAL-T model ( = 0.138), workload ( = -0.124), and perceived 
relative advantage ( = 0.112). The results partially supported hypothesis H1 that HIV care 
practitioners who perceived the HIVQUAL-T model to be simple and to have relatively greater 
advantage over other performance measurement methods were likely to put the HIVQUAL-T model 
into more extensive implementation. Unlike the study expectation, extensiveness of HIVQUAL-T 
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model implementation was negatively related to nurse-to-patient ratio (Workload), implying that 
HIV care practitioners with greater workload were more likely to extensively implement the 
HIVQUAL-T model. The four significant predictors accounted for 10% of the variation in 
extensiveness of the HIVQUAL-T model adoption.  
 
Figure 10. A Revised Covariance Structural Model of the Impacts of Perceived Innovation 
Characteristics on Hospitals‘ Extensiveness of the HIVQUAL-T Adoption 
 
As suggested by the modification indices for improving model performance, the 
measurement errors were correlated between Simple2 and Simple4, and Simple4, and Advantage4. In 
addition, Simplicity and Workload were found to be negatively correlated ( = 0.19). The model‘s 
goodness-of-fit was acceptable with χ2 = 91.381/31 df (p = 0.000), GFI and AGFI = 0.951 and 0.913, 
NFI = 0.926, TLI = 0.927, and RMSEA = 0.074. Although it was possible to obtain better model fit 
by correlating more measurement errors, further revision did not result in any significant decrease of 
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the χ2 value. Therefore, without compromising model parsimony, this revised model could be 
considered as robust. 
Influences of Organization Structural Characteristics on HIVQUAL-T Model Adoption  
and Organizational Performance 
 The implementation of HIVQUAL-T model was considered as organizational decision-
making. Although this study assumed that HIV care practitioners may play an important role in the 
implementation process (both performance measurement and quality improvement), implementation 
at the organizational level should also rely on the organization‘s readiness for the innovation. 
Consequently, the extent to which organizational structure and operations regarding the innovation 
may lead to better performance is the main focus in this study.  
The structural relationship of the Context-Design-Performance model is illustrated in a path 
diagram presented in Figure 11. In this model, three validated measurement models of organizational 
characteristics (the structural design dimension), namely Complexity, Interconnectedness, and Slack 
of Resources, were hypothesized to directly influence the observed endogenous variable, 
extensiveness of adoption (the operational design dimension), while an additional direct causal path 
was drawn from Extensiveness to the latent endogenous variable, HIV Services Performance, the 
final outcome of the path diagram (the performance dimension). RegRate, Size, and Workload were 
control variables representing additional context, structural design, and operational design 
dimensions. Each organization structural characteristics measurement model had four indicators, and 
the validated measurement model of HIV Services Performance contained six indicators. 
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Figure 11. A Generic Covariance Structural Model of HIVQUAL-T Model Adoption 
 
The path coefficients between organization structural characteristics, extensiveness of 
adoption, and HIV ambulatory services performance were estimated in order to examine the causal 
relationship among them. Table 10 illustrates standardized factor loadings, standardized path 
coefficients, and model fit statistics from the generic and revised covariance structural models. The 
parameter estimates from the generic model reveal that the path coefficients of the three structural 
design constructs—Complexity, Interconnectedness, and Slack—and the three control variables—
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Size, RegRate, and Workload—were all statistically significant, as well as Extensive (C.R. > 1.96 
and p-value < 0.05). However, the model fit statistics for the generic model suggested further 
modification by excluding Size from the model due to its high correlation with Complexity ( = 
0.95).  
Table 10. Parameter Estimates for the Analysis of Impacts of Organization Structural 
Characteristics on Extensiveness of HIVQUAL-T Model Adoption and HIV Ambulatory 
Services Performance 
 Generic Revised 
Effect Standardized 
Coefficients 
Critical 
Value 
Standardized 
Coefficients 
Critical Value 
Extensiveness  on   
HIV Services Performance 
 
0.338 
 
*5.220 
 
0.334 
 
*5.167 
Complexity      on  Extensiveness 0.133 *2.277  -- 
Interconnectedness  on Extensiveness 0.128 *2.087 0.130 *2.092 
Slack                on  Extensiveness 0.245 *2.850 0.254 *2.891 
Size                  on Extensiveness -0.143 *-2.727  -- 
RegRate           on  Extensiveness -0.163 *3.095 0.168 *3.147 
Workload         on  Extensiveness -0.160 *-3.036 -0.159 *-2.970 
R
2 
    
    Extensiveness 0.167  0.135  
    HIV Services Performance 0.114  0.112  
Goodness of Fit Statistics     
    χ2 765.650  132.911  
    df 201  113  
    χ2/df (p-value)  3.809 (0.000)  1.176 (0.097)  
    GFI 0.870  0.953  
    AGFI 0.836  0.937  
    NFI 0.625  0.858  
    TLI 0.641  0.970  
    RMSEA 0.095  0.024  
Note: -- Constructs were not included in the revised model. 
         *Critical ratio greater than 1.96 is considered statistically significant at the 0.05 level. 
The revised model in Figure 12 presented standardized path coefficients of all predictor 
variables. The model explained 11.2% of the variation of HIV ambulatory services performance. 
Extensiveness of HIVQUAL-T model implementation seemed to have proportionate impact on the 
hospital HIV services performance ( = 0.334), implying that hospitals that implemented the model 
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more extensively demonstrated better performance in 2009; thus hypothesis 3 was supported. It was 
noticed that Complexity became insignificant after removing Size from the model, which could 
imply that the significant contributions of these two variables found in the generic model may be due 
to their multicollinearity. When only Size or Complexity was included, neither presented statistical 
significance at all. Therefore, H2a was rejected. 
 
 
Figure 12. A Revised Covariance Structural Model of HIVQUAL-T Model Adoption and HIV 
Ambulatory Services Performance in Hospitals 
 
Among exogenous variables, Slack appeared to be the strongest predictor of extensiveness of 
HIVQUAL-T model adoption ( = 0.254), followed by RegRate ( = 0.168), Workload ( = -0.159), 
and Interconnectedness ( = 0.130). Those five predictors accounted for 13.5% of the variation in 
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extensiveness of adoption. These results supported the sub-hypotheses H2c and H2e that hospitals with 
more complex structure had more interactions to both internal and external organization, and those 
with greater resources implemented the HIVQUAL-T model more extensively. The overall 
assessment of fit of the revised model suggested an adequate fit of model to the data with χ2 = 
132.911/113 df (p = 0.097), GFI and AGFI = 0.953 and 0.937, NFI = 0.858, TLI = 0.970, and 
RMSEA = 0.024.  
Quality Improvement Trends 
 After confirming the impacts of the HIVQUAL-T model by comparing the performance 
between adopters and non-adopters, the presentation of the improvement trends among adopters 
could give additional support to the research findings whether the model did indeed improve HIV 
ambulatory services quality across time. According to panel information from BATS‘ HIV care 
performance dataset, 353 hospitals reported their performance consecutively from 2007 to 2009 in all 
HIV care indicators. The descriptive analysis demonstrating changes in average score of HIV 
services performance according to the eight indicators showed rapid improvement of the service 
provision from 2007 to 2008 in all indicators and more improvement in most indicators in 2009. For 
example, an average percentage of eligible patients receiving viral load screening increased from 
35.8% in 2007 to 78.3% in 2009, while an average percentage of eligible patients receiving cervical 
cancer screening (Pap smear) increased from 28.8% in 2007 to 69.6% in 2009. However, among 
some services for which average scores were relatively high, such as CD4 screening, PCP/Crypto 
prophylaxis, and ARV therapy, the increase rates from 2008 to 2009 appeared to decelerate. Figure 
13 presents national‘s average performance score for all indicators used in this study.  
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Figure 13. National Average Percentage of Eligible Patients Receiving HIV Care in Hospitals 
Implementing the HIVQUAL-T Model from 2007 - 2009  
 
In order to confirm hospitals‘ improvement in HIV ambulatory service performance between 
the years 2007 and 2009, a non-parametric statistic for paired-samples with non-normally distributed 
data, Wilcoxon Signed Ranks test, was performed. The results rejected the null hypothesis that the 
median difference between the members of each pair is equal to zero (p < 0.001). The positive mean 
difference between the average scores of 2009 and 2007 indicated that the performance among 
HIVQUAL-T model adopters improved after two years of implementation. However, the results 
from multivariate analysis demonstrated that implementation of HIVQUAL-T model accounted for 
only 11% of the variation in performance; thus, it must be noted that this univariate analysis results 
may not be adequate to prove that the improvement among the adopters is solely due to the 
implementation of the HIVQUAL-T model.  
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Chapter Summary 
 The study employed structural equation modeling (SEM) to examine the determinants of the 
HIVQUAL-T model adoption and its impact on HIV ambulatory services performance. Confirmatory 
factor analysis (CFA) was used to validate the measurement models of endogenous and exogenous 
theoretical constructs. A total of 11 measurement models for the latent constructs, including one 
measurement model of HIV services performance, five measurement models of perceived innovation 
attributes, and five measurement models of organization structural characteristics, were examined. 
All items were found to be valid measures for their constructs, except the items measuring 
centralization and formalization. Each measurement model was validated to reduce its complex 
dimensionality and obtain model fit.  
 Two covariance structural models were developed in this study. The first model illustrated 
the hypothesized causal relationship between innovation attributes perceived by HIV care 
practitioners in hospitals and the HIVQUAL-T model adoption. It was found that two of five 
constructs of innovation attributes, perceived relative advantage and perceived simplicity, positively 
contributed to the extensiveness of the implementation of the HIVQUAL-T model. Thus, hypothesis 
1 was partially supported.  
 The second model was based on the context-design-performance framework to systematically 
investigate the relationship between organization structural characteristics and extensiveness of the 
HIVQUAL-T model implementation in hospitals, and their relations to hospitals‘ HIV ambulatory 
services performance. Two structural characteristics; interconnectedness and organizational slack, 
appeared to have significant influence on hospitals‘ extensiveness of the HIVQUAL-T model 
implementation, which supported hypotheses 2c and 2e. In addition, control variables including rate 
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of adoption in a region and HIV clinic workload also significantly contributed to hospitals‘ extensive 
implementation of the model. Hospitals located in the region that had higher adoption rate were 
found to implement the model more extensively. However, higher HIV clinic workload, unlike the 
study expectation, led to more extensive implementation of the model. Most importantly, the 
extensiveness of the HIVQUAL-T model implementation was found to have positive impact on 
hospitals‘ HIV ambulatory services performance; therefore, hypothesis 3 was supported.   
 Overall, the study findings suggested that the degree to which hospitals would use the 
HIVQUAL-T model to assess their performance and then apply the performance results to conduct 
activities to improve their quality of HIV clinical services depended on both HIV care practitioners‘ 
perceptions about the difficulty and advantages of implementing the model and the degree of 
hospitals‘ interactions with others in terms of exchanging ideas and obtaining resources, internally 
and externally. The HIVQUAL-T model was found to be a quality improvement initiative that could 
improve hospitals‘ HIV ambulatory services performance in this study setting. 
 
 
CHAPTER FIVE: DISCUSSION 
  Based on diffusion of innovation theory, this study extended the focus from the 
determination of factors associated with individual and organizational adoption of an innovation to 
the extent that the innovation could reach its expected consequences. By using a survey instrument 
and Thailand‘s HIV care performance dataset, HIV ambulatory services performance was measured 
by multiple indicators according to baseline HIV care and treatment protocols while perceived 
innovation characteristics and organization structural design were measured by multiple survey 
items. Most measurement models of the constructs were confirmed by the obtained data. Hospitals‘ 
adoption-implementation behavior was proven to be the result of individual perceptions on 
innovation and organization structure and acted as an operational design factor that directly linked to 
performance. This chapter provides the discussion of major findings, theoretical and methodological 
issues drawn from research process and results, implications to policy and practice, limitations, and 
directions for future research.  
Major Findings 
 This study conducted a two-fold analysis. First, confirmatory factor analysis was performed 
for validating the measures of each theoretically based construct. Second, path analysis was 
performed to examine both the impacts of perceived innovation attributes on hospital‘s extensiveness 
of adoption and the impacts of organization structural characteristics on hospital‘s extensiveness of 
adoption with its contribution to improvement of HIV clinical services performance. The major 
findings of the three research questions are as follows: 
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Research Question 1: To what extent do innovation attributes, as perceived by HIV care 
practitioners, contribute to the variation in HIVQUAL-T model adoption among hospitals? 
 The study assumed that a hospital‘s decision to adopt HIVQUAL-T performance 
measurement software and further conduct quality improvement projects may depend on how HIV 
care practitioners who directly deal with these activities assess this HIV quality improvement tool 
prior to putting it into practice. The results indicated a significant positive relationship between two 
of the five perceived innovation attributes constructs—perceived simplicity and perceived relative 
advantage—and the extent to which hospitals implement the HIVQUAL-T model. These two 
exogenous variables, along with two control variables—rate of adoption in region and workload—
accounted for 10% of the total variance in the extensiveness of HIVQUAL-T model adoption. As 
indicated by the study result, the adoption is more likely when individual practitioners assess and 
find the innovation to be easy to comprehend and operate and also worthwhile to implement.  
In regard to relative advantage, which is usually found to be a significant contributing factor 
for innovation adoption, this result could confirm the findings of previous studies considering 
perceived innovation characteristics, such as Hung et al. (2010), Scott et al. (2008), Jerayaj et al. 
(2006), and Aubert and Hamel (2001). In addition, perceived simplicity was demonstrated as a 
significant predictor of organizational-level adoption in this study, while some previous studies found 
insignificant contribution (Damanpour & Schneider, 2008; Hung et al).  
In spite of their statistically insignificant impacts, observability and trialability appeared to 
have positive influences, while compatibility, not as expected, showed a negative coefficient. It was 
noticed that the modification indices for the generic model suggested intercorrelations among all 
perceived innovation attributes constructs, which would result in significant decrease in 2 value. For 
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example, simplicity and trialability seemed to be strongly correlated. It was probable that the 
inability to detect the impacts of trialability was due to a multicollinearity problem. This questionable 
observation was found to be possible when the impact of each construct on the dependent variable 
was tested individually and yielded a statistically significant relationship between trialability and 
extensiveness of adoption.  
The insignificant impact of observability could be due to the complex structure of the 
HIVQUAL-T model. Observability of the HIVQUAL-T model comprises at least three dimensions: 
the use of HIVQUAL-T software, quality improvement implementation, and the model‘s benefits in 
better HIV services performance, as seen from pilot implementers. The HIVQUAL-T model is 
similar to TQM, which is usually found to be less concrete (Projogo & Sohal, 2003; Rye & 
Kimberly, 2007; Young et al, 2001); thus, its operation may be less visible to others and its ability to 
generate visible results may be limited (Weiner et al., 2006). Additionally, the assessment of 
innovation benefits may not contribute to organizational-level decision making in the context that is 
subjected to a certain level of institutional influence, particularly in a health care setting that is 
considered to have a high degree of professionalism (Shortell & Kaluzny, 2006). As demonstrated in 
the structural model, rate of adoption in a region had the strongest contribution, which could imply 
that decision makers may adopt the model because they ‗know‘ that other hospitals in the same area 
are using the model, not because they ‗see‘ how this model worked in other hospitals.  
 The study results, similarly to other studies, still could not confirm the impact of 
compatibility on innovation adoption (Jerayaj et al., 2006); the direction of impact was negative. 
Since the HIVQUAL-T model is quite innovative in Thailand‘s HIV care setting, where there has 
been little experience in developing performance assessment software and implementing quality 
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improvement, practitioners may not be able to ‗match‘ the features of the model with their previous 
experiences and working styles.  
Research Question 2: To what extent do hospital structural characteristics contribute to the 
variation in HIVQUAL-T model adoption among hospitals? 
 In the attempts to develop measures for hospital structural characteristics variables, this study 
failed to validate two of the five constructs—centralization and formalization. Eventually, three 
constructs—complexity, interconnectedness, and slack of resources—were examined as determinants 
of organizational adoption of the HIVQUAL-T model. The study findings confirmed significant 
impacts of organizational interconnectedness and slack of resources, together with the control 
variables rate of adoption in region and workload. These significant variables accounted for 14% of 
the variation in extensiveness of HIVQUAL-T model adoption. Slack of resources appeared to make 
the strongest contribution to extensiveness. As indicated by the study results, HIVQUAL-T model 
adoption is more likely among hospitals that had more physical resources obtained from both internal 
and external sources for HIV-related activities and were more open to internal and external 
communication.  
 Organizational slack, in this study, was deemed to be a very significant contributing factor in 
explaining extensiveness of the HIVQUAL-T model adoption. According to Rogers (2003), 
organizational slack plays an important role, particularly for adoption of innovations that are higher 
in cost. In fact, performance measurement using the HIVQUAL-T software can be conducted at no 
cost; however, quality improvement activities require substantial commitment and efforts from both 
practitioners and hospitals, together with financial and technical support from external governmental 
and non-governmental funders. Hospitals that have more resources for their HIV clinics, thus, may 
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be more ready to move beyond performance measurement to quality improvement, compared to 
those that partially adopted or never adopted the model. Consistent with Kimberly and Cook‘s 
findings (2008), hospitals‘ slacks, such as adequacy of physical space, budgets, and use of computers 
for HIV service-related activities, were considered to be good measures for organizations‘ readiness 
for organizational change, which is influenced by implementation of innovations. 
 Significant influence of organizational interconnectedness could confirm the existence of 
both an internal and external social system of HIV care. A higher degree of internal network reflected 
by hospital-level meetings and external networks reflected by provincial, regional, and national level 
meetings could stimulate the flows of ideas about the importance of performance measurement and 
quality improvement using the HIVQUAL-T model. Interconnectedness may imply openness of 
organization in the sense that hospitals have mechanisms that allow information about the innovation 
to enter the hospitals (Kimberly, 1978) and allow HIV practitioners to obtain information via the 
involvement of professional associations (Damanpour & Schneider, 2008). Consequently, these 
aspects would facilitate the HIVQUAL-T model adoption.  
 The impact of complexity in this study was ambiguous due to its strong intercorrelation with 
hospital size. Removing either of them resulted in an insignificant path coefficient, indicating that 
neither complexity nor hospital size exerted significant influence on extensiveness of the HIVQUAL-
T model implementation despite their close relations, consistent with other studies‘ findings (e.g., 
Baldridge & Burnham, 1975). Measured primarily by the degree of specialization, organizational 
complexity in this context may not well predict the HIVQUAL-T model-related actions. Since the 
model generally emphasizes the improvement of the HIV ambulatory service delivery system, 
HIVQUAL-T operations put more focus on access to care, not direct clinical decisions such as 
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assigning ARV drug regimens or OI medications. Therefore, non-medical HIV care practitioners, 
such as hospital public health officers or HIV/AIDS coordinators, could conduct performance 
measurement and quality improvement with less degree of specialized practices. 
 Research Question 3: Do different levels of HIVQUAL-T model adoption contribute to the 
variation in HIV ambulatory care and treatment services performance among hospitals? 
The ultimate purpose of this study was to evaluate the effectiveness of the innovation, in 
other words, to examine the extent that the HIVQUAL-T model could attain its goal of improving 
quality in HIV ambulatory services. The confirmatory factor analysis for the focal endogenous 
variable HIV ambulatory services performance demonstrated a compact set of six HIV care 
indicators—CD4 screening, ART, PCP prophylaxis, TB screening, STDs screening, and PAP smears 
for women—for a single overall quality construct. These indicators were associated with each other 
but did not exhibit too strong an intercorrelation. The relationships among them could imply that they 
are the output of a single functional system so that efforts to improve quality should focus on 
characteristics of the system (Wilson et al., 2007). In improving such a system, extensive 
implementation of the HIVQUAL-T model was proven to be a significant factor, accounting for 11% 
of the variation in HIV ambulatory services performance among public hospitals in Thailand.  The 
study results point out that it is imperative for HIV care facilities to measure their performance in 
order to inform quality improvement initiatives specifically for individual clinics.  
Quality management models such as HIVQUAL-T are outcome based, and quality 
improvement is encouraged by performance assessment results with valid measures (Lilford, Brown, 
& Nicholl, 2007). Hospitals reported to implement quality improvement following the results from 
performance measurement exhibited better HIV ambulatory services performance than those reported 
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to be partial adopters or non-adopters, while partial adopters exhibited better performance as 
compared to non-adopters. Although partial adopters did not officially report quality improvement 
activities, the qualitative information obtained from the survey showed that many of them 
implemented QI without submitting proposals to BATS and NHSO, while some of them showed 
their intention to implement QI in later years. This finding suggested that these partial adopters were 
active in improving quality but they might not be ready yet to complete the whole model in the early 
adoption period. At any rate, organizational readiness could be a potential factor for organizational 
adoption of innovation and better quality.  
Theoretical and Methodological Issues 
Diffusion of Innovation Theory 
The results obtained from this study confirmed that attributes of innovation as perceived by 
intended users do influence innovation adoption. As mentioned, individual perception toward the 
innovation was assumed in this study to derive from HIV care practitioners‘ assessment. A question 
here is to what extent could all innovation characteristics, as proposed in this theory, be assessed? 
For some types of innovation, simplicity, relative advantage, and compatibility may be relatively 
easier to estimate at the stage of introduction without trying them out or seeing results from earlier 
adopters, while for other types of innovation, prospective adopters may have to try and observe the 
use of the innovation before deciding whether the innovation is desirable for them.  
In the case of the HIVQUAL-T model implementation, the existence of a strong positive 
correlation between simplicity and trialability or among other constructs may also imply overlapping 
conditions for such assessment. Those who had tried the performance measurement software would 
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be more familiar with it and would find that the software was easy to use, while this perception could 
be the opposite for those who had less chance to try it out. Furthermore, the complex structure of the 
HIVQUAL-T model that includes quality improvement implementation may make the model less 
trialable and observable in nature. Such an invisible part of the innovation may not be easy to assess 
before actual practice. Merely trying the performance measurement software may not confirm that 
quality improvement implementation would be compatible with the practitioners‘ working styles and 
experiences. Considering this information, perceived innovation attributes could be examined at a 
single point of time regarding their co-existence with each other or as sequential order when they are 
deemed to be consequences of the others. As suggested by Aubert and Hamel (2001), relative 
advantage could be determined by compatibility and ease of use.  
The conceptions and measures of those attributes formulated by previous studies, due to 
conventional factor analysis methods, were considered as aggregated components of the constructs 
without taking into consideration possible intercorrelations among them (e.g., Agarwal & Prasad, 
1997; Compeau et al., 2007; Moore & Benbasat, 1991; Hsu et al., 2007; Yang et al., 2009). This 
study anticipated that confirmatory factor analysis using SEM approach might somehow capture such 
relationships, which could contribute to a more precise understanding of these theoretical constructs.  
As the study findings demonstrated, all five perceived innovation attributes appeared to be 
intercorrelated, and such intercorrelation had resulted in the inability of the model to detect their 
actual impacts on the endogenous variable unless each construct was regressed separately. This 
finding led to an assumption that the five innovation attributes are not independent of each other and 
thus pointed out an option to re-conceptualize them as a multiple-factors attribute. For instance, 
instead of developing a single-factor measurement model for each construct separately, it may be 
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possible to build a five-factor measurement model for desirability of innovation attributes.  However, 
this proposition is not yet conclusive, since the results were drawn from only one study in one unique 
context; hence confirmation of the aforementioned intercorrelation is required.  
 Although organization structural characteristics constructs are all theoretically based, it was 
found to be difficult to measure some characteristics of organizational structure in this study. The 
failure to validate the measurement models of centralization and formalization in spite of adjusting 
their measures from previous studies in non-health care organizations (e.g., Aiken & Hage, 1966; 
Auh & Menguc, 2007; Dewar et al., 1980; Hage & Aiken, 1967), to some extent helps confirm the 
uniqueness of health care settings, where professionalism and specialization play significant roles in 
decision-making and practice.  
In regard to centralization, the average value of HIV care practitioners‘ autonomy to make 
decisions is quite high in every item, yet they appeared not to act in the same direction. Their 
participation in decision making to adopt and implement an innovation does not mean that they do 
not have to receive approval from supervisors. Likewise, formal HIV care and treatment protocol is 
mandatory in HIV care settings; nevertheless, non-medical HIV care practitioners such as HIV 
coordinators reported that they often provided some types of clinical care when necessary. These 
characteristics of HIV care in Thailand, therefore, may not be compatible with the measurement 
items. The development of centralization and formalization measures should thus put more 
consideration into organizational culture across different settings.  
Interestingly, it was found that two significant predictors, interconnectedness and adoption 
rate in region, implied an organization‘s embeddedness in a social system. This finding supported 
Rogers‘ statement that system norms tell individuals what behavior they are expected to perform; 
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thus, the system has a direct effect on diffusion (2003). An exchange of knowledge and institutional 
forces could stimulate innovation adoption. In addition, a significant contribution of organizational 
slack expresses the extent that organizations could obtain resources from internal and external 
environments. Although innovation theory does not put its emphasis mainly on contextual and 
environmental forces, organization structural characteristics proposed to associate with adoption 
under this perspective not only do point up organizational inertia but also already encapsulate 
organizational openness to environmental impacts. This observation is also consistent with findings 
from Marathe et al. (2007) and Naranjo-Gil (2009) that adopters were more sensitive to environment 
than to organizational factors.  
 Most importantly, this study applied a distinctive way of measuring innovation adoption and 
its effectiveness with lagged cross-sectional design, with which hospital performance was assessed 
after intervention implementation period. The HIVQUAL-T model, similar to other quality 
management initiatives such as total quality management, is considered a holistic approach to quality 
improvement, based on its identification of underlying causes of poor performance. Due to the 
uniqueness of the model, it was essential to consider the adoption-implementation as a multiple-steps 
practice, where the adopters may not be able to complete a whole process (performance measurement 
and quality improvement) under some conditions. Therefore, this study employed a diffusion of 
innovation perspective not only to predict adoption behaviors but also to assess organizational 
readiness to adopt and fully implement the innovation. The operational measurement of 
extensiveness of adoption may shed some light on how to capture actual levels of implementation, 
particularly those of administrative innovations that involve multiple activities to achieve expected 
outcomes.  
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Context-Design-Performance Framework 
 This study considered the application of SEM to be most suitable for an investigation of a 
‗social system‘ suggested by a diffusion of innovation perspective. The study adopted and applied the 
contingency perspective-based ‗Context-Design-Performance‘ analytical framework to portray the 
time-ordered relationship between each component. The results from path analysis, consistent with 
Wan‘s findings (2003), has confirmed the time-ordered process hypothesized by this framework, 
when organizational design was considered to encompass two sequential components, structural 
design and operational design, which finally lead to outcome. This relationship could be portrayed as 
Figure 14.  
 
 
 
Figure 14. Conceptual Linkages between Context-Structural Design-Operational Design-
Performance 
 
A significant contribution of rate of adoption in region implied that hospitals were prone to 
contextual influence, which worked in accordance with organizational structure to stimulate 
organizational operations (i.e., organizational decision-making and practices). Eventually, 
organizational operation was proved to act as a mediating factor or an intervention for improving 
organizational performance.  
Although this study did not include direct linkages between structural design and 
performance, the examination of those linkages was conducted in order to get some hints for possible 
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development of the context-design-performance model for future research. An additional path 
analysis performed to investigate the direct relationship between all structural variables and 
organizational performance presented significant contribution of organizational slack to hospitals‘ 
HIV ambulatory services performance, while complexity, interconnectedness, size, and workload 
were not found to be significant. Additional contribution of organizational slack in the tested model 
increased the proportion of variation in HIV care performance from 11% to 17%. 
It should be noted that organizational slack in this study context was measured by adequate 
budget from internal and external sources, physical space, and equipment availability, particularly for 
HIV clinics. Therefore, this structural aspect of hospitals would have an impact on performance in 
accordance with the HIV clinics‘ operations. Hospitals that have a higher degree of dedication to 
HIV care are thus more likely to provide better services. This finding indicates that structural 
characteristics may have direct influences on organizational performance when a structural aspect is 
closely related to a particular performance dimension. This observation is consistent with other 
studies in considering the relationship between structure and performance, in that some organization 
structural characteristics presented significant direct impacts only on some features of organizational 
performance, but indirectly on others through organizational practices (Keats & Hitt, 1988; Mark, 
Salyer, & Wan, 2003; Wan, 2003).  
As this study was limited in its measurement of structural characteristics of health care 
organization (i.e. centralization and formalization), while such inertia may also exercise influence as 
organizational slack of resources, further examination of the direct effects of validated constructs of 
organizational structure on organizational performance may improve the meaningful use of the C-D-
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P model, where a direct causal relationship could be depicted from structural design to performance 
as shown in Figure 14. 
The C-D-P model, as employed in this study, was proved to be valuable in determining the 
sequential relationship of all components in an entire social system in which organizations are 
embedded and influenced. The findings have highlighted the importance of understanding this 
interrelationship at both a macro and micro level, by which organizational structure and its 
interaction with environmental circumstances would stimulate and enable appropriate practices and 
finally lead to an improvement of outcomes. In addition, structural characteristics that have direct 
influence on performance could act as a mediator between context and organizational performance as 
well. This relationship could imply the importance of environment in determining quality at an 
aggregated stage, as could be seen from Thailand‘s HIV care environment, where the government‘s 
vigorous intervention might improve overall quality of HIV care at the national level.  Thus, 
achieving better quality of health care and services is a complex task for which the involvement of all 
stakeholders in a social system, including policy makers, organizational administrators, practitioners, 
and patients, is fundamental.  
Implications to Policy & Managerial Practices 
‘HIVQUAL’ Implementation in the Context of Thailand 
 The national-level adoption and implementation of the HIVQUAL-T model in Thailand 
implies the MOPH‘s strong commitment to improve quality of HIV care. Rogers (2003) stated that 
the fastest rate of adoption stems from authority decisions. The model‘s adoption rate is very rapid: 
76% of total hospitals (632 hospitals) in Thailand have already implemented at least the HIVQUAL-
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T software at the second year of the nationwide scaling up period. Although the Bureau of AIDS, 
TB, and STIs (BATS) expected that the expansion of the HIVQUAL-T system could cover 900 
hospitals in 2011, several issues pertaining the implementation of this initiative at the national level 
should be considered.  
 Over a hundred of the survey respondents provided a number of insightful comments on the 
implementation of the HIVQUAL-T model, comments that were consistent and explanative to the 
study‘s quantitative analysis results. In fact, all respondents, regardless of adopter or non-adopter 
status, agreed on the advantages of the HIVQUAL-T model for evaluating and improving HIV 
ambulatory service performance but mentioned several barriers to implementing the program at both 
macro and micro levels. These barriers are presumed to be due to the uniqueness of Thailand‘s HIV 
care context while some of them are similar to those of the HIVQUAL-US implementation (Drainoni 
et al., 2002; Warner et al., 2004;). 
 First, the HIVQUAL-T initiative in Thailand, probably because of its early period of 
nationwide implementation, appeared to focus mainly on two core components of the model, namely, 
performance measurement and quality improvement. Nevertheless, emphasis on the third core 
component of infrastructure development seemed to be limited. Guidance and financial support for 
building capacity to interpret performance data and implement QI processes is still essential, 
particularly for partial and non-adopters. Therefore, provincial public health, regional NHSO, and 
ODPC offices may act as active facilitators for interactive group learning with experienced 
implementers to provide updated information and training to encourage extensive and meaningful 
use of the model. More focus should be put on hospitals in regions with low adoption rate, where 
HIVQUAL-T-related activities were reported to be minimal. On-site monitoring to provide technical 
  
113 
support may also stimulate the use of the model. The emphasis on capacity building is imperative for 
the sustainability of the use of HIVQUAL-T, which the implementers are expected to independently 
use and integrate into their routine practice in the end.   
 Secondly, HIVQUAL-T software and its measurements are becoming more and more 
complex. Pilot implementers and early adopters are more familiar with using the software because 
they started this initiative from less complicated versions, while newer or prospective adopters would 
start from the most complex ones  (for example, HIVQUAL-T v.2.0 used during pilot 
implementation had only six core indicators while the current HIVQUAL-T v.5.0 includes all core 
indicators plus a variety of disease screenings, health promotion, and mental health assessment 
measures). As simplicity was found to be a significant factor for individual-level adoption, it should 
be taken into consideration that the HIVQUAL software was built to reduce review burden and 
generate facility-specific reports (Agins et al., 2004); thus, its application should be made simple to 
attract more prospective users and the requirements should be matched with the hospital‘s level of 
capacity. As suggested by the respondents, trainings on using the software should be provided on a 
regular basis in order to refresh and update their knowledge, at least once a year. In addition, some 
indicators could be made optional, particularly for community hospitals with low capacity of 
providing complex medical care and costly prophylactic medicine such as MAC prophylaxis 
(Wanleepong, Kulsomboon, & Ningsanond, 2010).  
Third, some implementers reported having difficulty in understanding items measuring HIV 
care among adopters due to the complex nature of HIV care and ambiguous questions asked by the 
software, which may lead to unreliable results or the implementers‘ inability to complete the 
assessment. In addition, QI implementation was perceived to be complicated in terms of writing 
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proposals, performing activities, and evaluating the outcomes. This issue could provide the 
proposition to the MOPH to develop a truly complete package of HIVQUAL-T in order to ensure the 
meaningful use and accurate understanding of the model, in particular its conception of measuring 
and improving HIV care quality. In developing quality measures, specification, scientific strength, 
reliability, validity, and interpretability of the measures should be carefully examined before actual 
use (McGlynn & Asch, 1998). 
 Fourth, organizational leadership and commitment are consistently reported to be potential 
barriers to quality improvement initiatives at the organizational level (Warner et al., 2004) and that 
failing applies to the context of HIVQUAL-T implementation without exception. This study believed 
that HIV practitioners might play an important role in the step of measuring their performance, while 
the implementation of QI activities relies more on organizational-level decision-making. This 
proposition is supported by the statements from both current and prospective implementers about the 
negligence from hospital boards or physicians to put focus on HIV care, particularly among hospitals 
that do not have a dedicated unit for HIV care. Some practitioners reported that they were not usually 
allowed to participate in any HIV-related training unless their names were indicated in official 
invitation letters sent to hospitals. Additionally, despite obvious assessment results provided by 
nurses, physicians or hospital boards may not approve or supply physical supports for QI activities 
for some particular domains. For the effectiveness of this implementation in such centralized and 
formalized setting, MOPH may use its bureaucratic channel of communication and enforcement by 
officially announcing a policy on assessing and improving HIV care quality to exert more pressure 
on hospital directors nationwide in responding to this initiative.  
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 Last, although the influence of workload on extensiveness of HIVQUAL-T model adoption 
was the reverse of the result expected by the study hypotheses, workload is indeed reported by the 
respondents as a significant barrier to the implementation. The positive impact of workload on 
adoption found in the quantitative analysis may have occurred because HIV care practitioners who 
had already implemented the model were those who could claim to have additional duties apart from 
their typical job description. In this sense, workload issue could be critical to the sustainability of the 
model and may lead to inactivation or disengagement of innovation (Drainoni et al., 2002). The 
MOPH‘s leadership in giving recognition such as rewarding or providing incentives to HIV care 
practitioners or hospitals may be a way to increase the implementers‘ satisfaction in performing this 
quality improvement initiative.  
HIV/AIDS Informatics: A Potential in Thailand’s HIV Care Setting 
  With both external supports from international organization and internal collaboration, 
Thailand now has a strong environment for monitoring, evaluating, and improving quality of HIV 
care using information technology. Several database systems have been developed for monitoring 
and evaluation of HIV-related programs and services in different HIV/AIDS populations (e.g. MSM 
HIV prevention program, National AIDS Program (NAP) database for HIV symptomatic and AIDS 
case reporting system, HIVQUAL-T, Perinatal HIV Outcome Monitoring system (PHOM), CHILD 
monitoring system, computerized STI records, and so on; see National AIDS Prevention an 
Alleviation Committee, 2010) However, there is reported to be some overlapping information across 
the systems that appeared to result in substantial workload for HIV care practitioners responsible for 
data collection and entry, as indicated by the respondents.  
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For example, the NAP electronics database contains a variety of modules for monitoring HIV 
services from registration to authorization of second-line ARV drugs to PMTCT, covering about 
60% of registered ART patients in Thailand, while the rest are reported through other systems 
(National AIDS Prevention and Alleviation Committee, 2010). Simultaneously, HIVQUAL-T covers 
most aspects of NAP with additional HIV care indicators not mandated by NHSO guidelines, such as 
PAP smear for women (Wanleepong et al., 2010) while it is charged with evaluating the performance 
of HIV services provided to the overall population, not only patients receiving ARV. In addition, 
hospital-level electronic medical records called HOSxP are claimed to contain all medical 
information for every patient receiving care from hospitals, which could provide general information 
for monitoring matters as well. Recently, the latest version of HIVQUAL-T software (v.5.3) was 
adjusted to connect with the NAP database for a more efficient data management process (BATS, 
2011). 
The fragmentation of HIV information systems raised the necessity for the  integration and 
development of Thailand‘s HIV/AIDS informatics to make monitoring and evaluation easier with 
quality data generated from different sources. The integration of information systems would create an 
HIV/AIDS data warehouse as a relational database for evidence-based medicine and care 
management. This integration would lead to efficiency in collecting and entering data for 
performance measurement as well as in saving costs of developing new systems and raising the 
effectiveness of provincial, regional, and national level outcome reporting and benchmarking for 
further improvement (Lee & Wan, 2003; Mettler & Rohner, 2009; Wan, 2002).  
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Limitations and Direction for Future Research 
 The study has several limitations that should be considered. The first limitation is in regard to 
the characteristics of research data. Although the sample was claimed to be a good representative of 
the study population, the information from non-adopters was limited. As reported previously, most 
observations removed from the analysis was due to missing information of non-adopters‘ 
performance results. The small proportion of non-adopters in this study may lead to interpretation 
bias of their poor performance as compared to the adopters. In addition, the majority of public 
hospitals in Thailand are community hospitals, accounting for more than 85% of the population, 
while general and regional hospitals account for only 15%. Hospitals in each category appeared to 
have substantial differences in terms of size and level of specialized care provided; therefore, 
multiple group analysis according to each hospital category might be more suitable for detecting such 
differences.  
 Second, the measurement of variables used in this study should be applied with caution. 
Despite its multidimensional nature, hospitals‘ HIV ambulatory services performance was measured 
by only six clinical service indicators and those may not be an absolute representation of quality 
measures. HIV care is considered multifaceted care, which could involve several levels of 
measurement. For example, HIV status monitoring encompasses CD4 and viral load screening, and 
opportunistic infection prophylaxis includes both primary and secondary prophylaxis as sub-
dimensions in relation to different diseases. Further development of measurement models for each 
category of care with detailed indicators would provide better understanding of HIV clinics‘ quality 
improvement choices and behaviors.  
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 Although most theoretical constructs were validated in this study, the confirmatory factor 
analyses demonstrated many overlapping aspects of perceived innovation attributes. Furthermore, 
two main structural characteristic constructs were found to be invalid. This situation may be due to 
the item questions, which were adapted from other studies unrelated to the health care setting. Since 
health care organizations are unique, particularly in terms of professionalism and specialization, the 
measurements for organization structural characteristics such as centralization and complexity should 
be developed specifically for the health care setting.  
 The operationalization of adoption variable as ordinal instead of dichotomous was believed to 
cover the two main phases of HIVQUAL-T model but at the expense of losing clear impacts of the 
determinants of innovativeness. Similar to what were noticed by many innovation researches, some 
characteristics of innovation and organization may present significant influence on one step of the 
initiative and have no effect on others. The perceptions of innovation characteristics prior to adoption 
decision-making may differ from the perceptions after the adoption, when adopters have had more 
chances to try the innovation. For example, some adopters may have adopted the software because it 
looked simple in the first place but later found that the actual use was not like what they had 
expected. In such a case the implementation could be inactive after the first year trial. On the other 
hand, some adopters may not have difficulty in using the software but may have limitations in 
writing and reporting quality improvement projects. Since this study viewed HIVQUAL-T model 
implementation as a longitudinal process, the factors derived from innovation perspectives could also 
be examined during the post-adoption period to determine the continuity of the implementation.  
 Third, this study was somewhat restricted to a theoretical framework; thus it may leave out 
other possible confounding factors associated with innovation adoption. The inclusion of more 
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environmental, organizational,  and managerial factors employed by other empirical studies related to 
innovation adoption in healthcare organizations would likely reduce error variance in the study and 
provide a more realistic explanation of organizational decision-making and performance. The 
improvement in quality regardless of HIVQUAL-T model adoption may occur due to a dynamic HIV 
care environment in which the government‘s emphasis on quality improvement became stronger 
during these few years. Thus, organizational and HIV care practitioners‘ attitudes and commitments 
on providing quality of HIV care services could also be potential factors in quality improvement.  
 Last, despite the use of a lagged cross-sectional design with non-adopters as the control 
group to capture the impacts of the innovation in a time-ordered manner, the interpretation of this 
study is not yet conclusive. The lagged cross-sectional design may not be able to cover actual lagged 
effects with the variation of time. Performance in this study is limited to the consequence of using a 
single intervention; however, the increase in performance scores across years found among 3-year 
adopters in this study could not be considered a pure impact of the HIVQUAL-T model. Moreover, 
while HIVQUAL-T performance measurement software can identify the deficiencies of each 
category of HIV clinical services, the quality improvement projects using such assessment results 
could not be executed to address all deficiencies at a single time or in a year or two, particularly in 
the case for which several insufficiencies of service were found during the first year of the 
assessment. Therefore, a longitudinal analysis to identify the actual lagged effects of this quality 
management initiative, with other possible factors facilitating its implementation and quality 
improvement, is recommended. 
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Conclusion 
The HIVQUAL model developed by NYS Department of Health, AIDS Institute was claimed 
to be a feasible way to monitor HIV care and one that can be adjusted for differences in guidelines, 
resources, and health care models (Agins et al., 2004). It could be considered as an evidenced-based 
quality improvement initiative, of which the measurement and focus can be adjusted to different 
settings. Shortell, Rundall, and Hsu (2007) saw quality management as an interdisciplinary approach 
that combines evidence-based medicine and evidence-based management together with scientific 
methodology. Using those facts, the adjustments of the model could make it culturally compatible 
with the values of health care professionals. This study has provided extensive analyses of the overall 
process of the HIVQUAL-T model initiative in Thailand, from considering HIV care practitioners‘ 
perception toward this innovation, to investigating organizational readiness in adopting and 
extensively implement the model, to demonstrating the effectiveness of this implementation in terms 
of improving HIV ambulatory services performance, in the hope that the lessons learned from 
Thailand would be a useful model for other developing countries in improving the quality of HIV 
care at any level.  
Chapter Summary 
 The analysis of the investigation of factors determining the extensiveness of the HIVQUAL-
T model adoption and its contribution to HIV ambulatory services performance provides several 
suggestions for successful implementation of the model at both the hospital and national levels. First, 
the focus on hospital-level capacity building is encouraged in order to enhance the meaningful use of 
this initiative, while the promotion of the use of the model should target low adoption areas. Second, 
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there should be a modification of the HIVQUAL-T model in order to make it more user friendly and 
less complex. Third, the specification, scientific strength, reliability, validity, and interpretability of 
the measures should be carefully examined before actual use. Fourth, organizational leadership and 
commitment to HIV care should be stimulated. Fifth, practitioners‘ dedication to HIV care should be 
recognized through rewarding or incentive mechanisms. The quantitative and qualitative information 
obtained from this study demonstrated Thailand‘s potential in developing HIV care information 
system integration to improve efficiency in data collection and utilization and effectiveness of 
reporting and benchmarking activities. 
 Several limitations of this study include limited access to non-adopters‘ performance 
information, the small proportion of general and regional hospitals, validity of theoretical constructs 
used in the study, and exclusion of possible confounding factors associated with adoption and 
performance. Future research with the inclusion of factors and development of constructs specific to 
healthcare organizations is encouraged, as well as a longitudinal design for capturing the HIVQUAL-
T model‘s lagged effects on HIV ambulatory services performance. 
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APPENDIX D: 
SUMMARY TABLE OF THE APPLICATION OF INNOVATION 
PERSPECTIVE IN HEALTH SERVICES RESEARCH  
 
 
Summary of Health Services Research on Innovation Adoption and Organizational Performance  
Year/Authors Title Unit of Analysis Independent Variables Significant Findings 
Aubert & Hamel 
(2001) 
Adoption of smart cards in 
the medical sector: the 
Canadian experience 
Health 
professionals and 
practitioners 
- Five innovation 
attributes suggested by 
Rogers (1995) 
- Image 
- Information 
- Involvement 
- Mandatoriness 
- Membership 
- Quality of the support 
- Satisfaction 
 
- Perceived usefulness, compatibility, and 
information positively contribute to 
perceived relative advantage. 
- Relative advantage is the most important 
factors to adoption.  
 
Durcharme et al. 
(2007) 
Innovation adoption in 
substance abuse treatment: 
Exposure, trialability, and 
the clinical trials network 
Clinical Trials 
Network programs 
- Exposure to clinical 
trails 
- Organizational 
characteristics 
- Direct exposure to buprenorphine clinical 
trials, treatment programs offering 
detoxification services, access to physicians, 
proportion of focal clients treated in the 
program positively associated with adoption.  
 
Escarce et al. (1995) Diffusion of Laparoscopic 
Cholecystectomy among 
general surgeons in the U.S. 
Surgeons - Competitiveness of 
practice 
- Health care market 
characteristics 
- Surgeons in more competitive practice 
settings and markets adopted the innovation 
earlier. 
- Free-for-service payment and competitive 
market are associated with early adoption. 
- The informational advantages of group 
practice hasten the adoption among surgeons 
in single-specialty but not multispecialty 
groups. 
 
Folland (1987) Advertising by physicians: 
behavior and attitudes 
physicians - demographical 
characteristics 
 
- The advertisers are significantly younger 
than their peers. 
- Advertising is more prominent among 
physicians in larger group practices, primary 
care physicians, and in prepayment contract. 
 
Hikmet et al. (2007) The role of organizational 
factors in the adoption of 
Hospitals - Organizational 
characteristics (size, 
- Hospital size has strongest effect on overall 
HIT, clinical, and strategic adoption. 
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Year/Authors Title Unit of Analysis Independent Variables Significant Findings 
HIT in Florida hospital system membership, tax 
status, geographical 
location) 
- Stand-alone, for-profit hospitals are likely 
to adopt administrative and strategic HIT.  
 
Hillmand & Schwartz 
(1985) 
The adoption and diffusion 
of CT and MRI in the U.S.: 
A comparative analysis 
MRI units in the 
U.S. 
- Technical uncertainty 
- Clinical advantage 
- Cost 
- Perceived profitability 
- Reimbursement policy 
- Market competition 
- Clinical advantage, cost, market 
competition, reimbursement policy and 
profitability positively contribute to the 
adoption. 
- Technical uncertainty negatively 
contributes to the diffusion of CT and MRI. 
 
Hung et al. (2010) Critical factors of hospital 
adoption on CRM system: 
Organizational and 
information system 
perspectives 
Hospitals - Size 
- Staff‘s IS capabilities 
- Innovation of senior 
executives 
- Knowledge 
management capabilities 
- Relative advantage 
- Complexity 
 
- Hospital size, staff‘s IS capabilities, 
innovation of senior executive, knowledge 
management capabilities, and relative 
advantage affect the CRMS adoption.  
Johnson et al. (1998) The impact of formalization, 
role conflict, role ambiguity, 
and communication quality 
on perceived organizational 
innovativeness in the cancer 
information service 
 
 
Individual 
practitioners in CIS 
network 
organizations  
- Formalization 
- Role Conflict 
- Role Ambiguity 
- Communication 
Quality 
- Formalization has both direct and indirect 
impacts on communication quality through 
role conflict and role ambiguity.  
- Communication quality has positive 
association with innovativeness. 
Kaluzny, Glasser, 
Gentry, & Sprague 
(1970) 
Diffusion of innovative 
health care services in the 
U.S.: A study of hospitals 
Hospitals - Location 
- Rural-urban nature of 
community 
- % Poverty 
- Type of hospital 
control 
- Hospital size 
- Greater implementation is associated with 
large voluntary hospitals, located in 
metropolitan areas, and in Northeastern 
states. 
- Hospitals within the low and medium 
poverty categories show early 
implementation of rehabilitation services. 
 
Kaluzny, Veney, & 
Gentry (1974) 
Innovation of health 
services: A comparative 
Hospitals and 
health department 
- Hospital size 
- Composition of 
- The more high-risk services provided the 
more such services an organization is likely 
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Year/Authors Title Unit of Analysis Independent Variables Significant Findings 
study of hospitals and health 
departments 
in NY  organization 
(cosmopolitan-oriented, 
degree of training) 
- Formalization 
 
to innovate. 
- Composition variables are central to 
innovation for low-risk services. 
- Size positively correlates with high-risk 
service in health department and low-risk 
services in hospitals. 
 
Kimberly (1978) Hospital adoption of 
innovation: The role of 
integration into external 
informational environments 
Hospitals - Hospital integration 
mechanisms 
- Structural constrains 
- Number of paid outside speakers, M.D. 
publication, hospital reimbursement for 
travel, and formally differentiated unit have 
positive effects on innovation.  
 
Kimberly & Evanisko 
(1981) 
Organizational innovation: 
The influence of individual, 
organizational, and 
contextual factors on 
hospital adoption of 
technological and 
administrative innovations 
Hospitals - Individual 
characteristics 
- Organizational 
characteristics 
- Contextual factors 
- Hospital administrator‘s educational level, 
committee participation, involvement in 
medical activities, chief of medicine‘s 
involvement in administrative activities, 
centralization, size, functional 
differentiation, competition, size of city and 
age positively contribute to the adoption of 
technological innovation. 
- HA cosmopolitanism, HA educational 
level, hospital size, and competition 
positively contribute to the adoption of 
administrative innovation. 
 
 
Knudsen, Roman, 
Johnson (2003) 
Organizational compatibility 
and workplace drug testing: 
Modeling the adoption of 
innovative social control 
practices 
Individual workers  - Type of industry 
- Size of industry 
- Rules orientation 
- Presence of employee 
assistance program 
- Machine control 
- Compatibility (as measured by rules 
orientation, presence of employee assistance 
program, and mechanization) is associated 
with the adoption of drug testing. 
- The adoption of drug testing varies across 
industries and by establishment size. 
 
Kovach, Morgan, 
Noonan, & Brondino 
(2008) 
Using principles of diffusion 
of innovation to improve 
nursing home care 
Nurses working in 
nursing homes 
Innovation (STI: Serial 
Trial Intervention 
principle) 
- Use of STI principle is associated with 
increased assessment in response to behavior 
change, increased administration of 
analgesics, and residents‘ decrease in 
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Year/Authors Title Unit of Analysis Independent Variables Significant Findings 
behavioral symptom. 
- The development on a facility action plan 
for and conduct staff education concerning 
the STI could lead to sustainability of the 
practice. 
 
Meyer, Johnson, & 
Ethington (1997)  
Contrasting attributes of 
preventive health 
innovations 
Individual 
members of health 
organizations in a 
network 
- Five perceive 
innovation attributes 
suggested by Rogers 
(1995) 
- Adaptability 
Riskiness 
- Acceptance 
 
- Innovation characteristics perceived by 
individuals are different across contrasting 
preventive health innovations.  
Moch & Morse (1977) Size, centralization, and 
organizational adoption of 
innovations 
Hospitals - Size 
- Functional 
differentiation 
- Centralization 
- Functional differentiation contributes to 
adoption. 
- Innovations compatible with interests of 
low-level decision makers are likely to be 
adopted in large, specialized, functionally 
differentiated, and decentralized hospitals.  
 
Naranjo-Gil (2009) The influence of 
environmental and 
organizational factors on 
innovation adoptions: 
consequences for 
performance in public sector 
organizations 
Hospitals - Organizational 
strategies 
- Firm size, 
- Uncertainty 
- Market concentration 
- Organizations that combine technical and 
administrative innovations increase their 
performance.  
- Prospector strategy has positive impact on 
administrative innovation. 
- Firm size has positive impact on 
technological innovation. 
- Environmental uncertainty and market 
concentration positively associated with both 
types of innovation. 
 
Panzano (2001) Moving from the diffusion 
of research results to 
promoting the adoption of 
evidence-based innovations 
in the Ohio mental health 
Mental health 
provider 
organizations 
- Perceived risk of 
adopting 
- Capacity to manage or 
absorb risk 
- Propensity to take risk 
- A decision to adopt is more likely when an 
organization has capacity to manage 
downside risk (e.g. slack resources are 
available) and when the organization has a 
past history or propensity to take risks. 
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Year/Authors Title Unit of Analysis Independent Variables Significant Findings 
system  
Scott et al. (2008) Factors influencing the 
adoption of an innovation: 
An examination of the 
uptake of the Canadian Heart 
Health Kit (HHK) 
Physicians - Five perceived 
innovation attributes 
suggested by Rogers 
(2003) 
- Barriers to use 
- Individual 
characteristics 
- Relative advantage, observability, and years 
of experience positively associated with 
intention to use the HHK.  
- The context within which adoption 
decisions are made affects the adoption 
process.  
 
Smythe (2002) Reputation, public 
information, and physician 
adoption of an innovation 
Physician - physician‘s acquired 
information 
- durability of reputation 
- physician‘s aversion to 
risk 
- uncertainty over impact 
on reputation 
- Physician uncertainty is driven by the 
durability of reputation, aversion to risk, and 
ability to acquire information. 
- Uncertainty negatively contributes to 
innovation adoption. 
- The belief that innovation is reputation 
enhancing have positive impact on initial 
adoption. 
 
Tung, Chang, & Chou 
(2008) 
An extension of trust and 
TAM model with IDT in the 
adoption of the electronic 
logistics information system 
in HIS in the medical 
industry 
Nurses  - compatibility 
- perceived usefulness 
- perceived ease of use 
- trust 
- perceived financial 
costs 
- Compatibility, perceived usefulness, 
perceived ease of use, and trust have positive 
influence on intention to use. 
- Perceived financial cost has negative 
influence on intention to use. 
 
Walston & Kimberly 
(2001) 
Institutional and economic 
influences on the adoption 
and extensiveness of 
managerial innovation in 
hospitals: The case of 
reengineering 
Hospitals - Economic pressure 
- Demand uncertainty 
- Rate of adoption in 
area 
- Timing 
- Size 
- Network linkage 
- Higher costs and a vulnerability to managed 
care contracting, rate of adoption in area 
positively contribute to adoption. 
- Greater HMO penetration and profit 
margins have negative impact on adoption. 
- Greater market competition and higher 
relative costs positively contribute to more 
extensive program implementation. 
- No. of physician-hospital activities, 
adoption of reengineering, and extensiveness 
of implementation are correlated. 
 
Yang, Yu, & Yang 
(2009) 
E-Health service in Taiwan- 
The role of organizational 
Individual 
employees 
- Compatibility 
- Personal 
- Compatibility and personal innovativeness 
indirectly contribute to attitude via perceived 
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Year/Authors Title Unit of Analysis Independent Variables Significant Findings 
innovativeness innovativeness 
- Organizational 
Innovativeness 
- Perceived usefulness 
- Perceived ease of use 
usefulness and ease of use.  
- Organizational innovativeness has direct 
impact on attitude. 
 
Young, Charns, & 
Shortell (2001) 
Top manager and network 
effects on the adoption of 
innovative management 
practices: A study of TQM 
in a public hospital system 
Hospitals - Personal characteristics 
(top manager) 
- Network/ institutional 
arrangement 
- Age of hospital director has negative 
impact on TQM adoption. 
- Hospital director‘s possessions of a 
graduate degree and prior exposure to TQM, 
and cumulative number of adopters in the 
area and network have positive association to 
adoption.  
- The impacts vary across different adoption 
periods. 
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